PC3
MCID: PCH010
MIFTS: 44

Pachyonychia Congenita 3 (PC3)

Categories: Fetal diseases, Genetic diseases, Oral diseases, Rare diseases, Skin diseases

Aliases & Classifications for Pachyonychia Congenita 3

MalaCards integrated aliases for Pachyonychia Congenita 3:

Name: Pachyonychia Congenita 3 56 73 29 6 71
Pc3 56 73
Pachyonychia Congenita, Type 3 39
Pc-3 17

Classifications:



Summaries for Pachyonychia Congenita 3

OMIM : 56 Pachyonychia congenita (PC) is an autosomal dominant genodermatosis with the main clinical features of hypertrophic nail dystrophy, painful and highly debilitating plantar keratoderma, oral leukokeratosis, and a variety of epidermal cysts. Although the condition had previously been subdivided clinically into Jadassohn-Lewandowsky PC type 1 and Jackson-Lawler PC type 2, patients with PC were later found to have a mixed constellation of both types, leading to a classification of PC based on genotype (summary by Sybert, 2010; Eliason et al., 2012; McLean et al., 2011). For a discussion of genetic heterogeneity of pachyonychia congenita, see 167200. (615726)

MalaCards based summary : Pachyonychia Congenita 3, also known as pc3, is related to prostate cancer and suppression of tumorigenicity 12. An important gene associated with Pachyonychia Congenita 3 is KRT6A (Keratin 6A). The drugs Remifentanil and Narcotics have been mentioned in the context of this disorder. Affiliated tissues include prostate, bone and breast, and related phenotypes are hyperhidrosis and palmoplantar keratoderma

UniProtKB/Swiss-Prot : 73 Pachyonychia congenita 3: An autosomal dominant genodermatosis characterized by hypertrophic nail dystrophy, painful and highly debilitating plantar keratoderma, oral leukokeratosis, and a variety of epidermal cysts.

Related Diseases for Pachyonychia Congenita 3

Diseases in the Pachyonychia Congenita, Autosomal Recessive family:

Pachyonychia Congenita 1 Pachyonychia Congenita 2
Pachyonychia Congenita 3 Pachyonychia Congenita 4

Diseases related to Pachyonychia Congenita 3 via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 90, show less)
# Related Disease Score Top Affiliating Genes
1 prostate cancer 11.0
2 suppression of tumorigenicity 12 10.4
3 insulin-like growth factor i 10.3
4 retinoblastoma 10.3
5 pertussis 10.3
6 insulinoma 10.3
7 familial retinoblastoma 10.3
8 severe combined immunodeficiency 10.3
9 48,xyyy 10.3
10 bone resorption disease 10.3
11 skin disease 10.2
12 hypoxia 10.2
13 pituitary tumors 10.2
14 osteogenic sarcoma 10.2
15 fibrosarcoma 10.2
16 combined t cell and b cell immunodeficiency 10.2
17 rapidly involuting congenital hemangioma 10.2
18 breast cancer 10.1
19 prostate cancer, hereditary, 3 10.1
20 familial adenomatous polyposis 10.1
21 small cell carcinoma 10.1
22 prostatitis 10.1
23 cholera 10.1
24 adenocarcinoma 10.1
25 vaccinia 10.1
26 pituitary adenoma 10.1
27 adenoma 10.1
28 hypertriglyceridemia, familial 10.1
29 multicentric carpotarsal osteolysis syndrome 10.1
30 glioblastoma multiforme 10.1
31 neuroblastoma 10.1
32 neurofibromatosis, type ii 9.9
33 alopecia, androgenetic, 1 9.9
34 colorectal cancer 9.9
35 hypercholesterolemia, familial, 1 9.9
36 endosteal hyperostosis, autosomal dominant 9.9
37 medulloblastoma 9.9
38 antigen defined by monoclonal antibody aj9 9.9
39 pheochromocytoma 9.9
40 greig cephalopolysyndactyly syndrome 9.9
41 triiodothyronine receptor auxiliary protein 9.9
42 ataxia-telangiectasia 9.9
43 hypogonadotropic hypogonadism 1 with or without anosmia 9.9
44 prostatic hyperplasia, benign 9.9
45 leukemia, acute myeloid 9.9
46 hemophagocytic lymphohistiocytosis, familial, 2 9.9
47 nasopharyngeal carcinoma 9.9
48 acute promyelocytic leukemia 9.9
49 gastric cancer 9.9
50 pulmonary hypertension, primary, 2 9.9
51 mulchandani-bhoj-conlin syndrome 9.9
52 helix syndrome 9.9
53 androgenic alopecia 9.9
54 adrenal gland pheochromocytoma 9.9
55 autosomal recessive cerebellar ataxia 9.9
56 prostatic hypertrophy 9.9
57 telangiectasis 9.9
58 neuroendocrine carcinoma 9.9
59 prostatic adenoma 9.9
60 kallmann syndrome 9.9
61 cervical adenocarcinoma 9.9
62 b-cell lymphoma 9.9
63 alopecia 9.9
64 cytomegalovirus infection 9.9
65 cerebrofacial arteriovenous metameric syndrome 9.9
66 pre-descemet corneal dystrophy 9.9
67 argyria 9.9
68 pancreatic cancer 9.9
69 ataxia and polyneuropathy, adult-onset 9.9
70 leukemia, acute lymphoblastic 9.9
71 colorectal adenocarcinoma 9.9
72 bone disease 9.9
73 lymphocytic leukemia 9.9
74 neutropenia 9.9
75 dysentery 9.9
76 leukemia 9.9
77 urethritis 9.9
78 cystitis 9.9
79 hyperinsulinism 9.9
80 iron metabolism disease 9.9
81 astrocytoma 9.9
82 breast adenocarcinoma 9.9
83 hyperglycemia 9.9
84 acute t cell leukemia 9.9
85 myeloid leukemia 9.9
86 skin melanoma 9.9
87 microcephaly 9.9
88 cytokine deficiency 9.9
89 lymphosarcoma 9.9
90 precursor t-cell acute lymphoblastic leukemia 9.9

Graphical network of the top 20 diseases related to Pachyonychia Congenita 3:



Diseases related to Pachyonychia Congenita 3

Symptoms & Phenotypes for Pachyonychia Congenita 3

Human phenotypes related to Pachyonychia Congenita 3:

31 (showing 11, show less)
# Description HPO Frequency HPO Source Accession
1 hyperhidrosis 31 HP:0000975
2 palmoplantar keratoderma 31 HP:0000982
3 nail dystrophy 31 HP:0008404
4 gingivitis 31 HP:0000230
5 furrowed tongue 31 HP:0000221
6 oral leukoplakia 31 HP:0002745
7 plantar hyperkeratosis 31 HP:0007556
8 onychogryposis of toenails 31 HP:0008401
9 epidermoid cyst 31 HP:0200040
10 palmar hyperkeratosis 31 HP:0010765
11 chapped lip 31 HP:0040181

Clinical features from OMIM:

615726

Drugs & Therapeutics for Pachyonychia Congenita 3

Drugs for Pachyonychia Congenita 3 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 24, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Remifentanil Approved Phase 4 132875-61-7 60815
2 Narcotics Phase 4
3 Anesthetics Phase 4
4 Analgesics Phase 4
5 Central Nervous System Depressants Phase 4
6 Analgesics, Opioid Phase 4
7
Paclitaxel Approved, Vet_approved Phase 3 33069-62-4 36314
8
Epirubicin Approved Phase 3 56420-45-2 41867
9
Cyclophosphamide Approved, Investigational Phase 3 6055-19-2, 50-18-0 2907
10
Carboplatin Approved Phase 3 41575-94-4 10339178 498142 38904
11 Antimitotic Agents Phase 3
12 Alkylating Agents Phase 3
13 Immunosuppressive Agents Phase 3
14 Anti-Bacterial Agents Phase 3
15 Immunologic Factors Phase 3
16 Antibiotics, Antitubercular Phase 3
17 Albumin-Bound Paclitaxel Phase 3
18 Topoisomerase Inhibitors Phase 3
19 Antirheumatic Agents Phase 3
20
Gefitinib Approved, Investigational Phase 2 184475-35-2 123631
21
Docetaxel Approved, Investigational Phase 2 114977-28-5 148124
22 Protein Kinase Inhibitors Phase 2
23
Parathyroid hormone Approved, Investigational 9002-64-6
24 Liver Extracts

Interventional clinical trials:

(showing 6, show less)
# Name Status NCT ID Phase Drugs
1 Effect of Two Plasma Concentrations of Remifentanil Through Target Controlled Anesthesia on Frequency and Intensity of Coughing During Extubation: Randomized Controlled Clinical Trial Completed NCT02711904 Phase 4 Extubation U;Extubation T
2 Randomized Phase Ⅲ Trial Comparing Dose-dense Epirubicin and Cyclophosphamide Followed by Paclitaxel With Paclitaxel Plus Carboplatin as Adjuvant Therapy for Triple-negative Breast Cancer. Unknown status NCT01378533 Phase 3 epirubicin, cyclophosphamide, paclitaxel, carboplatin, G-CSF
3 Phase II Trial of Neoadjuvant Docetaxel and ZD 1839 (Iressa) Followed by Radical Prostatectomy in Patients With High Risk, Locally Advanced Prostate Cancer Completed NCT00242918 Phase 2 docetaxel;ZD1839
4 Effect and Mechanism of Acupuncture on Patients With Functional Dyspepsia: a Protocol for a Randomized, Assessor-blind, Sham-controlled Trial Unknown status NCT02358486
5 Improving Pain Management in Cancer Care Completed NCT00036829
6 Intervention Based on the Use of Patient Feedback Collected for Improving Patient Safety in Spanish Primary Care (PC) Centres Not yet recruiting NCT03837912

Search NIH Clinical Center for Pachyonychia Congenita 3

Genetic Tests for Pachyonychia Congenita 3

Genetic tests related to Pachyonychia Congenita 3:

# Genetic test Affiliating Genes
1 Pachyonychia Congenita 3 29 KRT6A

Anatomical Context for Pachyonychia Congenita 3

MalaCards organs/tissues related to Pachyonychia Congenita 3:

40
Prostate, Bone, Breast, Endothelial, Lung, Colon, Bone Marrow

Publications for Pachyonychia Congenita 3

Articles related to Pachyonychia Congenita 3:

(showing 7117, show less)
# Title Authors PMID Year
1
Two novel de novo mutations of KRT6A and KRT16 genes in two Chinese pachyonychia congenita pedigrees with fissured tongue or diffuse plantar keratoderma. 56 6
22668561 2012
2
The genetic basis of pachyonychia congenita. 56 6
16250206 2005
3
Novel and recurrent mutations in the genes encoding keratins K6a, K16 and K17 in 13 cases of pachyonychia congenita. 56 6
11886499 2001
4
Mutation of a type II keratin gene (K6a) in pachyonychia congenita. 56 6
7545493 1995
5
Pachyonychia congenita in pediatric patients: natural history, features, and impact. 56
24132595 2014
6
A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita. 56
22264670 2012
7
The phenotypic and molecular genetic features of pachyonychia congenita. 56
21430705 2011
8
Pachyonychia Congenita 6
20301457 2006
9
A mutation in human keratin K6b produces a phenocopy of the K17 disorder pachyonychia congenita type 2. 56
9618173 1998
10
A mutation in the mucosal keratin K4 is associated with oral white sponge nevus. 6
7493030 1995
11
Biological Synthesis of CdTe Quantum Dots and Their Anti-Proliferative Assessment Against Prostate Cancer Cell Line. 61
31748032 2020
12
Anisamide-functionalized pH-responsive amphiphilic chitosan-based paclitaxel micelles for sigma-1 receptor targeted prostate cancer treatment. 61
31826492 2020
13
Antioxidation and Antiapoptosis Characteristics of Heme Oxygenase-1 Enhance Tumorigenesis of Human Prostate Carcinoma Cells. 61
31810001 2020
14
Active mixture of serum-circulating small molecules selectively inhibits proliferation and triggers apoptosis in cancer cells via induction of ER stress. 61
31669205 2020
15
The heat shock protein 70 inhibitor VER155008 suppresses the expression of HSP27, HOP and HSP90β and the androgen receptor, induces apoptosis, and attenuates prostate cancer cell growth. 61
31222811 2020
16
Synergistic combination treatment to break cross talk between cancer cells and bone cells to inhibit progression of bone metastasis. 61
31654872 2020
17
CXCL11 promotes tumor progression by the biased use of the chemokine receptors CXCR3 and CXCR7. 61
31437604 2020
18
Peimine inhibits the growth and motility of prostate cancer cells and induces apoptosis by disruption of intracellular calcium homeostasis through Ca2+ /CaMKII/JNK pathway. 61
31081133 2020
19
The dietary combination of essential oils and organic acids reduces Salmonella enteritidis in challenged chicks. 61
31393588 2019
20
Stanniocalcin-1 protein expression profile and mechanisms in proliferation and cell death pathways in prostate cancer. 61
31816356 2019
21
MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF. 61
30669858 2019
22
A Novel Small Molecule Inhibits Tumor Growth and Synergizes Effects of Enzalutamide on Prostate Cancer. 61
31582422 2019
23
Synthesis and preclinical validation of novel P2Y1 receptor ligands as a potent anti-prostate cancer agent. 61
31831761 2019
24
(E)-N'-Arylidene-2-(4-oxoquinazolin-4(3H)-yl) acetohydrazides: Synthesis and evaluation of antitumor cytotoxicity and caspase activation activity. 61
30734614 2019
25
Global and region-specific post-transcriptional and post-translational modifications of bisphenol A in human prostate cancer cells. 61
31610501 2019
26
Knockdown of COPS3 inhibits the progress of prostate cancer through reducing phosphorylated p38 MAPK expression and impairs the epithelial-mesenchymal transition process. 61
31509289 2019
27
Cytotoxic Stilbenes and Canthinone Alkaloids from Brucea antidysenterica (Simaroubaceae). 61
31816856 2019
28
Development of selective mono or dual PROTAC degrader probe of CDK isoforms. 61
31846828 2019
29
"A Sweet Combination": Developing Saccharin and Acesulfame K Structures for Selectively Targeting the Tumor-Associated Carbonic Anhydrases IX and XII. 61
31794211 2019
30
Enhancement of curcumin antitumor efficacy and further photothermal ablation of tumor growth by single-walled carbon nanotubes delivery system in vivo. 61
31578087 2019
31
Ligands dissociation induced gold nanoparticles aggregation for colorimetric Al3+ detection. 61
31585569 2019
32
Design, synthesis, and biological evaluation of novel androst-17β-amide structurally related compounds as dual 5α-reductase inhibitors and androgen receptor antagonists. 61
31469015 2019
33
Synthesis and cytotoxic activities of novel copper and silver complexes of 1,3-diaryltriazene-substituted sulfonamides. 61
30362387 2019
34
Mixed ligand complexes of Co(II), Ni(II) and Cu(II) with quercetin and diimine ligands: synthesis, characterization, anti-cancer and anti-oxidant activity. 61
31832781 2019
35
Kochia scoparia seed extract suppresses VEGF-induced angiogenesis via modulating VEGF receptor 2 and PI3K/AKT/mTOR pathways. 61
31608754 2019
36
Stylosin and some of its synthetic derivatives induce apoptosis in prostate cancer cells as 15-lipoxygenase enzyme inhibitors. 61
31297564 2019
37
Photoirradiation after aminolevulinic acid treatment suppresses cancer cell proliferation through the HO-1/p21 pathway. 61
31404677 2019
38
Nonradioactive Cell Assay for the Evaluation of Modular Prostate-Specific Membrane Antigen Targeting Ligands via Inductively Coupled Plasma Mass Spectrometry. 61
31714783 2019
39
The Effect of Chirality on the Application of 5-[18F]Fluoro-Aminosuberic Acid ([18F]FASu) for Oxidative Stress Imaging. 61
31792837 2019
40
γ-(S)-Guanidinylmethyl-Modified Triplex-Forming Peptide Nucleic Acids Increase Hoogsteen-Face Affinity for a MicroRNA and Enhance Cellular Uptake. 61
31206960 2019
41
Evaluation of L-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of Cancer. 61
30815792 2019
42
Sericin grafted multifunctional curcumin loaded fluorinated graphene oxide nanomedicines with charge switching properties for effective cancer cell targeting. 61
31678390 2019
43
In vitro antitumor activity, ADME-Tox and 3D-QSAR of synthesized and selected natural styryl lactones. 61
31480006 2019
44
Pomegranate Juice and Peel Extracts are Able to Inhibit Proliferation, Migration and Colony Formation of Prostate Cancer Cell Lines and Modulate the Akt/mTOR/S6K Signaling Pathway. 61
31838616 2019
45
Novel human Ab against vascular endothelial growth factor receptor 2 shows therapeutic potential for leukemia and prostate cancer. 61
31578782 2019
46
Apoptosis: A target for anticancer therapy with novel cyanopyridines. 61
31837830 2019
47
Isolation, characterization, and bioactivities of compounds from Fuscoporia torulosa mushroom. 61
31599026 2019
48
Novel tertiary sulfonamide derivatives containing benzimidazole moiety as potent anti-gastric cancer agents: Design, synthesis and SAR studies. 61
31577977 2019
49
Anticancer Activity of Earthworm Powder (Lumbricus terrestris) Against MCF-7 and PC-3 Cancer Cell Lines. 61
31321664 2019
50
Effects of gametogenetin-binding protein 2 on proliferation, invasion and migration of prostate cancer PC-3 cells. 61
31797427 2019
51
Evaluation of the CRISPR/Cas9 directed mutant TP53 gene repairing effect in human prostate cancer cell line PC-3. 61
31571107 2019
52
Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist 177 Lu-DOTAGA-PEG2 -RM26. 61
31077356 2019
53
Mdm2-P53 Interaction Inhibitor with Cisplatin Enhances Apoptosis in Colon and Prostate Cancer Cells In-Vitro. 61
31759358 2019
54
New pyrimidine-benzoxazole/benzimidazole hybrids: Synthesis, antioxidant, cytotoxic activity, in vitro cyclooxygenase and phospholipase A2-V inhibition. 61
31536956 2019
55
Characterization of HMGB1/2 Interactome in Prostate Cancer by Yeast Two Hybrid Approach: Potential Pathobiological Implications. 61
31694235 2019
56
GPR75 receptor mediates 20-HETE-signaling and metastatic features of androgen-insensitive prostate cancer cells. 61
31760076 2019
57
Alpha-PET for Prostate Cancer: Preclinical investigation using 149Tb-PSMA-617. 61
31780798 2019
58
Capsaicin suppressed activity of prostate cancer stem cells by inhibition of Wnt/β-catenin pathway. 61
31782192 2019
59
Preclinical evaluation of a 64Cu-labeled disintegrin for PET imaging of prostate cancer. 61
31621030 2019
60
Rooibos suppresses proliferation of castration-resistant prostate cancer cells via inhibition of Akt signaling. 61
31419729 2019
61
Ligand induced dissociation of the AR homodimer precedes AR monomer translocation to the nucleus. 61
31723170 2019
62
Isoquinolinamine FX-9 Exhibits Anti-Mitotic Activity in Human and Canine Prostate Carcinoma Cell Lines. 61
31703454 2019
63
Dual VEGFR-2/PIM-1 kinase inhibition towards surmounting the resistance to antiangiogenic agents via hybrid pyridine and thienopyridine-based scaffolds: Design, synthesis and biological evaluation. 61
31473473 2019
64
2-Styryl-4-aminoquinazoline derivatives as potent DNA-cleavage, p53-activation and in vivo effective anticancer agents. 61
31761381 2019
65
Design, synthesis and biological evaluation of new Axl kinase inhibitors containing 1,3,4-oxadiazole acetamide moiety as novel linker. 61
31757525 2019
66
Betulinic Acid, the first lupane-type triterpenoid isolated via bioactivity-guided fractionation, and identified by spectroscopic analysis from leaves of Nyctanthes arbor-tristis: its potential biological activities in vitro assays. 61
29724132 2019
67
Selection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26. 61
31745219 2019
68
Eriocalyxin B Induces Apoptosis and Autophagy Involving Akt/Mammalian Target of Rapamycin (mTOR) Pathway in Prostate Cancer Cells. 61
31714902 2019
69
Comparison of biological properties of [177 Lu]Lu-ProBOMB1 and [177 Lu]Lu-NeoBOMB1 for GRPR-targeting. 61
31715025 2019
70
MicroRNA-143-3p targets pyruvate carboxylase expression and controls proliferation and migration of MDA-MB-231 cells. 61
31697914 2019
71
Novel 3,4-dihydro-4-oxoquinazoline-based acetohydrazides: Design, synthesis and evaluation of antitumor cytotoxicity and caspase activation activity. 61
31479984 2019
72
Design, synthesis and anticancer evaluation of novel 1,3-benzodioxoles and 1,4-benzodioxines. 61
31421253 2019
73
Overexpression of SOCS3 mediated by adenovirus vector in mouse and human castration-resistant prostate cancer cells increases the sensitivity to NK cells in vitro and in vivo. 61
30607005 2019
74
Analysis of the Potential for N4-Hydroxycytidine to Inhibit Mitochondrial Replication and Function. 61
31767721 2019
75
β2AR-HIF-1α-CXCL12 signaling of osteoblasts activated by isoproterenol promotes migration and invasion of prostate cancer cells. 61
31771535 2019
76
Induction of sub-G0 arrest and apoptosis by seed extract of Moringa peregrina (Forssk.) Fiori in cervical and prostate cancer cell lines. 61
31669164 2019
77
Procaspase-3 Overexpression in Cancer: A Paradoxical Observation with Therapeutic Potential. 61
31260254 2019
78
Pyrazolo-benzothiazole hybrids: Synthesis, anticancer properties and evaluation of antiangiogenic activity using in vitro VEGFR-2 kinase and in vivo transgenic zebrafish model. 61
31445229 2019
79
New flavonoids, emarginin A-C from Vaccinium emarginatum Hayata. 61
31790770 2019
80
Triterpenoids from the barks of Juglans hopeiensis. 61
31778881 2019
81
Optimized Anti-Prostate-Specific Membrane Antigen Single-Chain Variable Fragment-Loaded Nanobubbles as a Novel Targeted Ultrasound Contrast Agent for the Diagnosis of Prostate Cancer. 61
31702068 2019
82
2-Deoxyglycoside Conjugates of Lupane Triterpenoids with High Cytotoxic Activity-Synthesis, Activity, and Pharmacokinetic Profile. 61
31553559 2019
83
Macroline-Sarpagine Bisindole Alkaloids with Antiproliferative Activity from Alstonia penangiana. 61
31642315 2019
84
Design, synthesis and biological evaluation of novel indole-based oxalamide and aminoacetamide derivatives as tubulin polymerization inhibitors. 61
31753698 2019
85
Discovery and optimization of 5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one derivatives as mTORC1/mTORC2 dual inhibitors. 61
31526911 2019
86
A quantitative study of intercellular heterogeneity in gold nanoparticle uptake across multiple cell lines. 61
31691854 2019
87
Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies. 61
31718684 2019
88
Cross-Linked Polyphenol-Based Drug Nano-Self-Assemblies Engineered to Blockade Prostate Cancer Senescence. 61
31553876 2019
89
Cancer-associated fibroblast regulate proliferation and migration of prostate cancer cells through TGF-β signaling pathway. 61
31465732 2019
90
Leelamine Is a Novel Lipogenesis Inhibitor in Prostate Cancer Cells In Vitro and In Vivo. 61
31395683 2019
91
Glucosinolate-Degradation Products as Co-Adjuvant Therapy on Prostate Cancer in Vitro. 61
31600887 2019
92
Buforin IIb induces androgen-independent prostate cancer cells apoptosis though p53 pathway in vitro. 61
31229626 2019
93
3D porous chitosan-alginate scaffold stiffness promotes differential responses in prostate cancer cell lines. 61
31279100 2019
94
Nanoscale AFM-IR spectroscopic imaging of lipid heterogeneity and effect of irradiation in prostate cancer cells. 61
31300624 2019
95
Molecular signatures associated with prostate cancer cell line (PC-3) exposure to inactivated Zika virus. 61
31653965 2019
96
Importance of activated leukocyte cell adhesion molecule (ALCAM) in prostate cancer progression and metastatic dissemination. 61
31695844 2019
97
MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2. 61
31696466 2019
98
Brevifoliol ester induces apoptosis in prostate cancer cells by activation of caspase pathway. 61
31585016 2019
99
JAB1/COPS5 is a putative oncogene that controls critical oncoproteins deregulated in prostate cancer. 61
31434609 2019
100
Screening, identification of prostate cancer urinary biomarkers and verification of important spots. 61
30610587 2019
101
The bispecific anti-CD3 × anti-CD155 antibody mediates T cell immunotherapy for human prostate cancer. 61
30374653 2019
102
Structurally Modified Cyclopenta[b]benzofuran Analogues Isolated from Aglaia perviridis. 61
31621322 2019
103
Discovery, synthesis and molecular substantiation of N-(benzo[d]thiazol-2-yl)-2-hydroxyquinoline-4-carboxamides as anticancer agents. 61
31382059 2019
104
Tyrosine-based asymmetric urea ligand for prostate carcinoma: Tuning biological efficacy through in silico studies. 61
31404798 2019
105
Migration and Invasion Enhancer 1 Is an NF-ĸB-Inducing Gene Enhancing the Cell Proliferation and Invasion Ability of Human Prostate Carcinoma Cells In Vitro and In Vivo. 61
31581708 2019
106
New steroidal oxazolines, benzoxazoles and benzimidazoles related to abiraterone and galeterone. 61
31678134 2019
107
Discovery of novel pyrimidine-based benzothiazole derivatives as potent cyclin-dependent kinase 2 inhibitors with anticancer activity. 61
31254921 2019
108
Peptide-based targeted polymeric nanoparticles for siRNA delivery. 61
31295734 2019
109
Synthesis, biological evaluation and molecular docking of 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs containing the piperazine moiety. 61
31493989 2019
110
Exploring New Structural Features of the 18β-Glycyrrhetinic Acid Scaffold for the Inhibition of Anaplastic Lymphoma Kinase. 61
31597403 2019
111
Determination of cell nucleus-to-cytoplasmic ratio using imaging flow cytometry and a combined ultrasound and photoacoustic technique: a comparison study. 61
31625322 2019
112
Apoptosis induction in lung and prostate cancer cells through silver nanoparticles synthesized from Pinus roxburghii bioactive fraction. 61
31641851 2019
113
Novel GH-20 β-N-acetylglucosaminidase inhibitors: Virtual screening, molecular docking, binding affinity, and anti-tumor activity. 61
31593714 2019
114
Contemporary analysis of the effect of marital status on survival of prostate cancer patients across all stages: A population-based study. 61
31103337 2019
115
Enhancement of anticancer activity of docetaxel by combination with Fuzheng Yiliu decoction in a mouse model of castration-resistant prostate cancer. 61
31545228 2019
116
Synthesis, Anticancer and Antibacterial Activity of Betulinic and Betulonic Acid C-28-Triphenylphosphonium Conjugates with Variable Alkyl Linker Length. 61
31660842 2019
117
The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway. 61
31448674 2019
118
Identification and characterization of protein phosphorylation in the soluble protein fraction of scallop (Chlamys farreri) byssus. 61
31264161 2019
119
The rhenium(I)-diselenoether anticancer drug targets ROS, TGF-β1, VEGF-A, and IGF-1 in an in vitro experimental model of triple-negative breast cancers. 61
30632005 2019
120
Structural and biological study of synthesized anthraquinone series of compounds with sulfonamide feature. 61
30489230 2019
121
Strength Development and Strain Localization Behavior of Cemented Paste Backfills Using Portland Cement and Fly Ash. 61
31601013 2019
122
Design, synthesis and biological evaluation of new steroidal β-triazoly enones as potent antiproliferative agents. 61
31229507 2019
123
Interference of Seasonal Variation on the Antimicrobial and Cytotoxic Activities of the Essential Oils from the Leaves of Iryanthera polyneura in the Amazon Rain Forest. 61
31441194 2019
124
Amide-tethered quinoline-resorcinol conjugates as a new class of HSP90 inhibitors suppressing the growth of prostate cancer cells. 61
31349117 2019
125
Design, synthesis, cytotoxicity screening and molecular docking of new 3-cyanopyridines as survivin inhibitors and apoptosis inducers. 61
31679838 2019
126
Two new pregnane steroidal glycosides from Cynanchum taihangense. 61
31581856 2019
127
Development of Improved Tumor-Residualizing, GRPR-Targeted Agents: Preclinical Comparison of an Endolysosomal Trapping Approach in Agonist and Antagonistic Constructs. 61
31601697 2019
128
Sulfonamide phenylalanine (SPA) series of analogues as an antibacterial, antifungal, anticancer agents along with p53 tumor suppressor-DNA complex inhibitor - part 1. 61
31547774 2019
129
Charge-conversion and ultrasound-responsive O-carboxymethyl chitosan nanodroplets for controlled drug delivery. 61
31271101 2019
130
Identification and characterization of oligomeric proanthocyanidins with significant anti-cancer activity in adzuki beans (Vigna angularis). 61
31687492 2019
131
Synthesis of Novel Analogs of Thieno[2,3-d] Pyrimidin-4(3H)-ones as Selective Inhibitors of Cancer Cell Growth. 61
31640194 2019
132
A Novel FGFR3 Splice Variant Preferentially Expressed in African American Prostate Cancer Drives Aggressive Phenotypes and Docetaxel Resistance. 61
31266816 2019
133
Predictive factors for survival outcomes of oligometastatic prostate cancer patients treated with metastases-directed therapy: a recursive partitioning-based analysis. 61
31444549 2019
134
Topological properties and in vitro identification of essential nodes of the Paclitaxel and Vincristine interactomes in PC-3 cells. 61
31783991 2019
135
CID-6033590 inhibits p38MAPK pathway and induces S-phase cell cycle arrest and apoptosis in DU145 and PC-3 cells. 61
31175925 2019
136
Water soluble, optically active monofunctional Pd(ii) and Pt(ii) compounds: promising adhesive and antimigratory effects on human prostate PC-3 cancer cells. 61
31482936 2019
137
Antitumor activity of an Artemisia annua herbal preparation and identification of active ingredients. 61
31132755 2019
138
Calcitonin induces stem cell-like phenotype in prostate cancer cells. 61
31561211 2019
139
Targeted Regulation of miR-26a on PTEN to Affect Proliferation and Apoptosis of Prostate Cancer Cells. 61
31135180 2019
140
FENDRR reduces tumor invasiveness in prostate cancer PC-3 cells by targeting CSNK1E. 61
31539119 2019
141
Preclinical Evaluation and Pilot Clinical Study of Al18F-PSMA-BCH for Prostate Cancer PET Imaging. 61
30796170 2019
142
Design and synthesis of phenylpiperazine derivatives as potent anticancer agents for prostate cancer. 61
31148379 2019
143
EHMT2 promotes the development of prostate cancer by inhibiting PI3K/AKT/mTOR pathway. 61
31599405 2019
144
Chinese Herbal Medicine Ganoderma tsugae Displays Potential Anti-Cancer Efficacy on Metastatic Prostate Cancer Cells. 61
31500366 2019
145
T-type calcium channels drive the proliferation of androgen-receptor negative prostate cancer cells. 61
31334879 2019
146
Evaluation of neurotensin receptor 1 as potential biomarker for prostate cancer theranostic use. 61
31264168 2019
147
Reversal of the Warburg phenomenon in chemoprevention of prostate cancer by sulforaphane. 61
31555797 2019
148
Prostate carcinoma cell-derived exosomal MicroRNA-26a modulates the metastasis and tumor growth of prostate carcinoma. 61
31229922 2019
149
In Vitro Antitumor Evaluation of Some Hybrid Molecules Containing Coumarin and Quinolinone Moieties. 61
31566140 2019
150
Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo. 61
31548560 2019
151
Metal Incorporated g-C₃N₄ Nanosheets as Potential Cytotoxic Agents for Promoting Free Radical Scavenging in Cancer Cell Lines. 61
30961695 2019
152
Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine and quinazoline derivatives as potent antitumor agents. 61
31280016 2019
153
Distinct biological responses of metastatic castration resistant prostate cancer cells upon exposure to G-quadruplex interacting naphthalenediimide derivatives. 61
31158753 2019
154
Discovery of 2,4-diarylaminopyrimidine derivatives bearing dithiocarbamate moiety as novel FAK inhibitors with antitumor and anti-angiogenesis activities. 61
31129452 2019
155
Oxime-based 19-nortestosterone-pheophorbide a conjugate: bimodal controlled release concept for PDT. 61
31414695 2019
156
A New Histone Deacetylase Inhibitor, MHY4381, Induces Apoptosis via Generation of Reactive Oxygen Species in Human Prostate Cancer Cells. 61
31476841 2019
157
Novel mechanism of endocrine disruption by fungicides through binding to the membrane androgen receptor, ZIP9 (SLC39A9), and antagonizing rapid testosterone induction of the intrinsic apoptotic pathway. 61
31152826 2019
158
Novel Poly(Adenosine Diphosphate-Ribose) Polymerase (PARP) Inhibitor, AZD2461, Down-Regulates VEGF and Induces Apoptosis in Prostate Cancer Cells 61
31102368 2019
159
Cellulase productivity of Trichoderma reesei mutants developed in Japan varies with varying pH conditions. 61
30975564 2019
160
Synthesis and anticancer activity of some pyrido[2,3-d]pyrimidine derivatives as apoptosis inducers and cyclin-dependent kinase inhibitors. 61
31544523 2019
161
Castanea sativa Mill. Shells Aqueous Extract Exhibits Anticancer Properties Inducing Cytotoxic and Pro-Apoptotic Effects. 61
31546790 2019
162
Phenylpropanoids and lignoids from the whole plant of Vaccinium emarginatum and their cytotoxicity against prostate cancer cells. 61
31496280 2019
163
Synthesis of novel S-linked dihydroartemisinin derivatives and evaluation of their anticancer activity. 61
31216504 2019
164
Combination of Proton Therapy and Radionuclide Therapy in Mice: Preclinical Pilot Study at the Paul Scherrer Institute. 61
31480730 2019
165
Design, Synthesis, and Biological Evaluation of Novel Thienopyrimidine Derivatives as PI3Kα Inhibitors. 61
31547116 2019
166
Inorganic Selenium Induces Nonapoptotic Programmed Cell Death in PC-3 Prostate Cancer Cells Associated with Inhibition of Glycolysis. 61
31513389 2019
167
The effect of curcumin in antitumor photodynamic therapy: In vitro experiments with Caco-2 and PC-3 cancer lines. 61
31100447 2019
168
Apoptotic activity of xanthoquinodin JBIR-99, from Parengyodontium album MEXU 30054, in PC-3 human prostate cancer cells. 61
31433962 2019
169
Gummosin, a sesquiterpene coumarin from Ferula assa-foetida is preferentially cytotoxic to human breast and prostate cancer cell lines. 61
31516858 2019
170
Long non-coding RNA-NEAT1, a sponge for miR-98-5p, promotes expression of oncogene HMGA2 in prostate cancer. 61
31481527 2019
171
In-air production of 3D co-culture tumor spheroid hydrogels for expedited drug screening. 61
31200118 2019
172
Paradoxical Role of Glypican-1 in Prostate Cancer Cell and Tumor Growth. 61
31391540 2019
173
SIRT1 Modulates the Sensitivity of Prostate Cancer Cells to Vesicular Stomatitis Virus Oncolysis. 61
31092575 2019
174
MiR-1266 suppresses the growth and metastasis of prostate cancer via targeting PRMT5. 61
31378882 2019
175
Expression of KIF18A Is Associated with Increased Tumor Stage and Cell Proliferation in Prostate Cancer. 61
31451680 2019
176
Secreted frizzled-related protein 5 suppresses aggressive phenotype and reverses docetaxel resistance in prostate cancer. 61
30787036 2019
177
Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer. 61
31134301 2019
178
Long noncoding RNA LEF1-AS1 silencing suppresses the initiation and development of prostate cancer by acting as a molecular sponge of miR-330-5p via LEF1 repression. 61
30613973 2019
179
Synthesis and evaluation of the antitumor activity of Calix[4]arene l-proline derivatives. 61
31451296 2019
180
Synthesis and biological evaluation of PSMA-targeting paclitaxel conjugates. 61
31248772 2019
181
Paederia foetida induces anticancer activity by modulating chromatin modification enzymes and altering pro-inflammatory cytokine gene expression in human prostate cancer cells. 61
31112703 2019
182
Cell Responses to Electrical Pulse Stimulation for Anticancer Drug Release. 61
31430890 2019
183
Evaluation of Tumor-Targeting Properties of an Antagonistic Bombesin Analogue RM26 Conjugated with a Non-Residualizing Radioiodine Label Comparison with a Radiometal-Labelled Counterpart. 61
31382362 2019
184
Biological activities of marine invertebrates extracts from the northeast brazilian coast. 61
31389485 2019
185
In vitro and computational studies showed that perezone inhibits PARP-1 and induces changes in the redox state of K562 cells. 61
31063714 2019
186
Bruceadysentoside A, a new pregnane glycoside and others secondary metabolites with cytotoxic activity from brucea antidysenterica J. F. Mill. (simaroubaceae). 61
31434501 2019
187
Isolation and characterization of a novel oligomeric proanthocyanidin with significant anti-cancer activities from grape stems (Vitis vinifera). 61
31427660 2019
188
Tumor Cell Behavior in Porous Hydrogels: Effect of Application Technique and Doxorubicin Treatment. 61
31502133 2019
189
Synthesis and cytotoxicity of the conjugates of diterpenoid isosteviol and N-acetyl-D-glucosamine. 61
31402704 2019
190
Anticancer Activity of Water-Soluble Olsalazine-PAMAM-Dendrimer-Salicylic Acid-Conjugates. 61
31412571 2019
191
Excess hepsin proteolytic activity limits oncogenic signaling and induces ER stress and autophagy in prostate cancer cells. 61
31399560 2019
192
Comparative evaluation of the new GRPR-antagonist 111 In-SB9 and 111 In-AMBA in prostate cancer models: Implications of in vivo stability. 61
30963606 2019
193
Cytotoxicity screening of supercritical fluid extracted seaweeds and phenylpropanoids. 61
31004301 2019
194
Achieving the balance: Biphasic effects of genistein on PC-3 cells. 61
31368541 2019
195
Silymarin Enriched Extract (Silybum marianum) Additive Effect on Doxorubicin-Mediated Cytotoxicity in PC-3 Prostate Cancer Cells. 61
31288278 2019
196
Esterified Derivatives of Panaxadiol and Their Inhibitory Effect on HL-60, THP-1, and PC-3 Cell Lines. 61
31298488 2019
197
Effects of dihydroartemisinin on HSP70 expression in human prostate cancer PC-3 cells. 61
30972796 2019
198
Upregulation of Scavenger Receptor B1 Is Required for Steroidogenic and Nonsteroidogenic Cholesterol Metabolism in Prostate Cancer. 61
31064850 2019
199
Glycyrrhiza glabra-Enhanced Extract and Adriamycin Antiproliferative Effect on PC-3 Prostate Cancer Cells. 61
31274029 2019
200
Targeting lactate dehydrogenase‑A promotes docetaxel‑induced cytotoxicity predominantly in castration‑resistant prostate cancer cells. 61
31180564 2019
201
EGF-activated PI3K/Akt signalling coordinates leucine uptake by regulating LAT3 expression in prostate cancer. 61
31345230 2019
202
Lupane Triterpenoids and New Derivatives as Antiproliferative Agents Against Prostate Cancer Cells. 61
31262911 2019
203
An integrated PKD1-dependent signaling network amplifies IRE1 prosurvival signaling. 61
31167779 2019
204
Synthesis of Usnic Acid Derivatives and Evaluation of Their Antiproliferative Activity against Cancer Cells. 61
31282672 2019
205
Structure-Guided Design, Synthesis, and Biological Evaluation of (2-(1H-Indol-3-yl)-1H-imidazol-4-yl)(3,4,5-trimethoxyphenyl) Methanone (ABI-231) Analogues Targeting the Colchicine Binding Site in Tubulin. 61
31251599 2019
206
Ascomylactams A-C, Cytotoxic 12- or 13-Membered-Ring Macrocyclic Alkaloids Isolated from the Mangrove Endophytic Fungus Didymella sp. CYSK-4, and Structure Revisions of Phomapyrrolidones A and C. 61
31251621 2019
207
A nanodroplet cell processing platform facilitating drug synergy evaluations for anti-cancer treatments. 61
31300742 2019
208
Cytoprotective Compounds Interfere with the Nutraceutical Potential of Bread Supplemented with Green Coffee Beans. 61
31330944 2019
209
Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer. 61
31340483 2019
210
Doxorubicin induces prostate cancer drug resistance by upregulation of ABCG4 through GSH depletion and CREB activation: Relevance of statins in chemosensitization. 61
30834613 2019
211
Characterization of an in vitro model to study the possible role of polyomavirus BK in prostate cancer. 61
30515818 2019
212
Comparative Study of Subcutaneous and Orthotopic Mouse Models of Prostate Cancer: Vascular Perfusion, Vasculature Density, Hypoxic Burden and BB2r-Targeting Efficacy. 61
31366895 2019
213
New Trisulfated Steroids from the Vietnamese Marine Sponge Halichondria vansoesti and Their PSA Expression and Glucose Uptake Inhibitory Activities. 61
31357591 2019
214
Carvacrol Induced Program Cell Death and Cell Cycle Arrest in Androgen-Independent Human Prostate Cancer Cells via Inhibition of Notch Signaling. 61
31364516 2019
215
Design, synthesis and biological evaluation of benzimidazole derivatives as novel human Pin1 inhibitors. 61
31103446 2019
216
Preclinical investigations and first-in-human application of 152Tb-PSMA-617 for PET/CT imaging of prostate cancer. 61
31346796 2019
217
The rBC2LCN-positive subpopulation of PC-3 cells exhibits cancer stem-like properties. 61
31133376 2019
218
Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway. 61
30889629 2019
219
Discovery of 18F-JK-PSMA-7, a PET Probe for the Detection of Small PSMA-Positive Lesions. 61
30389823 2019
220
Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer. 61
31241767 2019
221
Modulatory Effect of Selected Dietary Phytochemicals on Delayed Rectifier K+ Current in Human Prostate Cancer Cells. 61
31165179 2019
222
Downregulated NOX4 underlies a novel inhibitory role of microRNA-137 in prostate cancer. 61
30637800 2019
223
Inhibition of GLS suppresses proliferation and promotes apoptosis in prostate cancer. 61
31196962 2019
224
Rosa canina Extract has Antiproliferative and Proapoptotic Effects on Human Lung and Prostate Cancer Cells. 61
31184219 2019
225
New Insights into the Role of Polybromo-1 in Prostate Cancer. 61
31212728 2019
226
Paclitaxel resistance and the role of miRNAs in prostate cancer cell lines. 61
30244336 2019
227
Effect of citrus peel extracts on the cellular quiescence of prostate cancer cells. 61
31169845 2019
228
Metastatic prostate cancer cells are highly sensitive to 3-bromopyruvic acid. 61
30928407 2019
229
Nitrogen-containing derivatives of O-tetramethylquercetin: Synthesis and biological profiles in prostate cancer cell models. 61
30904813 2019
230
miR-93-5p may be an important oncogene in prostate cancer by bioinformatics analysis. 61
30582208 2019
231
Antitumor effect of a dual cancer-specific oncolytic adenovirus on prostate cancer PC-3 cells. 61
30665692 2019
232
HLA-DQB1 Position 57 Defines Susceptibility to Isolated and Polyglandular Autoimmunity in Adults: Interaction With Gender. 61
30590628 2019
233
Enhanced Allicin Cytotoxicity on HEPG-2 Cells Using Glycyrrhetinic Acid Surface-Decorated Gelatin Nanoparticles. 61
31460232 2019
234
2,4-Disubstituted quinazolines targeting breast cancer cells via EGFR-PI3K. 61
30939352 2019
235
Ectopic expression of CC chemokine receptor 7 promotes prostate cancer cells metastasis via Notch1 signaling. 61
30548287 2019
236
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo. 61
30933831 2019
237
In Vitro and In Vivo Evaluation of Antitumor Activity of Ligustrum robustum, A Chinese Herbal Tea. 61
29790063 2019
238
Synthesis and Evaluation of Novel Pyrazole Ethandiamide Compounds as Inhibitors of Human THP-1 Monocytic Cell Neurotoxicity. 61
31261948 2019
239
Photoradiosynthesis of 68Ga-Labeled HBED-CC-Azepin-MetMAb for Immuno-PET of c-MET Receptors. 61
31117346 2019
240
New Ophiobolin Derivatives from the Marine Fungus Aspergillus flocculosus and Their Cytotoxicities against Cancer Cells. 61
31212583 2019
241
Deubiquitinase USP9X regulates the invasion of prostate cancer cells by regulating the ERK pathway and mitochondrial dynamics. 61
31002345 2019
242
Design, Synthesis and Biological Evaluation of a New Series of 1-Aryl-3-{4-[(pyridin-2-ylmethyl)thio]phenyl}urea Derivatives as Antiproliferative Agents. 61
31167363 2019
243
Characterization of H2S releasing properties of various H2S donors utilizing microplate cover-based colorimetric assay. 61
30946806 2019
244
The targeting of MTDH by miR‑145‑5p or miR‑145‑3p is associated with prognosis and regulates the growth and metastasis of prostate cancer cells. 61
31081051 2019
245
Anticancer evaluation of a novel dithiocarbamate hybrid as the tubulin polymerization inhibitor. 61
31183632 2019
246
2-Methyl-versiquinazoline C, a new fumiquinazoline-type alkaloid from the fungus Aspergillus flavipes PJ03-11. 61
29693414 2019
247
Dammarane-type triterpenoids from the stem of Ziziphus glaziovii Warm. (Rhamnaceae). 61
30965192 2019
248
Design, synthesis, and biological evaluation of tetrahydroisoquinoline-based diaryl urea derivatives for suppressing VEGFR-2 signaling. 61
30531369 2019
249
New analogs of SYA013 as sigma-2 ligands with anticancer activity. 61
30987780 2019
250
Comparative Analysis of Lycopene Content from Different Tomato-Based Food Products on the Cellular Activity of Prostate Cancer Cell Lines. 61
31185698 2019
251
Suppression of STAT3 Phosphorylation and RelA/p65 Acetylation Mediated by MicroRNA134 Plays a Pivotal Role in the Apoptotic Effect of Lambertianic Acid. 61
31248140 2019
252
Antimicrobial property and antiproliferative activity of Centaurea babylonica (L.) L. on human carcinomas and cervical cancer cell lines. 61
31232061 2019
253
Effective enmein-type mimics of clinical candidate HAO472: Design, synthesis and biological evaluation. 61
30921757 2019
254
Synthesis, Anticancer Activity on Prostate Cancer Cell Lines and Molecular Modeling Studies of Flurbiprofen-Thioether Derivatives as Potential Target of MetAP (type II). 61
31203805 2019
255
Production of highly thermo-tolerant laccase from novel thermophilic bacterium Bacillus sp. PC-3 and its application in functionalization of chitosan film. 61
30573384 2019
256
Heavy Metals in Suspended Particulate Matter of the Zhujiang River, Southwest China: Contents, Sources, and Health Risks. 61
31137629 2019
257
Multiphoton fluorescence lifetime imaging microscopy (FLIM) and super-resolution fluorescence imaging with a supramolecular biopolymer for the controlled tagging of polysaccharides. 61
31046042 2019
258
Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells. 61
31060628 2019
259
MicroRNA‑302a upregulation mediates chemo‑resistance in prostate cancer cells. 61
30942454 2019
260
Low-dose curcuminoid-loaded in dextran nanobubbles can prevent metastatic spreading in prostate cancer cells. 61
30654342 2019
261
Alternol eliminates excessive ATP production by disturbing Krebs cycle in prostate cancer. 61
30663084 2019
262
TRPM2 mediates distruption of autophagy machinery and correlates with the grade level in prostate cancer. 61
30888515 2019
263
Human GPRC6A Mediates Testosterone-Induced Mitogen-Activated Protein Kinases and mTORC1 Signaling in Prostate Cancer Cells. 61
30894404 2019
264
Effect of docetaxel on the regulation of proliferation and apoptosis of human prostate cancer cells. 61
30864701 2019
265
Estrogen receptor β suppresses inflammation and the progression of prostate cancer. 61
30864712 2019
266
Novel Thienopyrimidine Derivative, RP-010, Induces β-Catenin Fragmentation and Is Efficacious against Prostate Cancer Cells. 61
31126091 2019
267
Interleukin-7 Contributes to the Invasiveness of Prostate Cancer Cells by Promoting Epithelial-Mesenchymal Transition. 61
31061414 2019
268
Modelling the internalisation process of prostate cancer cells for PSMA-specific ligands. 61
31260881 2019
269
Anti-Cancer Activity of Novel Dihydrotestosterone-Derived Ring A-Condensed Pyrazoles on Androgen Non-Responsive Prostate Cancer Cell Lines. 61
31052484 2019
270
The impact of Catechol-O-methyl transferase knockdown on the cell proliferation of hormone-responsive cancers. 61
30904591 2019
271
Development of Bispecific NT-PSMA Heterodimer for Prostate Cancer Imaging: A Potential Approach to Address Tumor Heterogeneity. 61
31034212 2019
272
Design and synthesis of new substituted spirooxindoles as potential inhibitors of the MDM2-p53 interaction. 61
30802707 2019
273
Long noncoding RNA LINC00662 functions as miRNA sponge to promote the prostate cancer tumorigenesis through targeting miR-34a. 61
31114993 2019
274
MicroRNA‑9 suppresses human prostate cancer cell viability, invasion and migration via modulation of mitogen‑activated protein kinase kinase kinase 3 expression. 61
30896820 2019
275
Plant origin authentication of Sonoran Desert propolis: an antiproliferative propolis from a semi-arid region. 61
31069518 2019
276
Combination of metformin and paclitaxel suppresses proliferation and induces apoptosis of human prostate cancer cells via oxidative stress and targeting the mitochondria-dependent pathway. 61
30944622 2019
277
Piperine blocks voltage gated K+ current and inhibits proliferation in androgen sensitive and insensitive human prostate cancer cell lines. 61
31047869 2019
278
Two new physalin derivatives from Physalis alkekengi L. var. franchetii (Mast.) Makino. 61
31140313 2019
279
Mechanism of selective anticancer activity of isothiocyanates relies on differences in DNA damage repair between cancer and healthy cells. 61
31123866 2019
280
Kenalactams A-E, Polyene Macrolactams Isolated from Nocardiopsis CG3. 61
31021629 2019
281
Polydopamine-decorated tobacco mosaic virus for photoacoustic/magnetic resonance bimodal imaging and photothermal cancer therapy. 61
31066418 2019
282
LncRNA UCA1 acts as a sponge of miR-204 to up-regulate CXCR4 expression and promote prostate cancer progression. 61
30940776 2019
283
The effect of the overexpression of miR-490 on the biological function of prostate cancer cell PC-3. 61
31424678 2019
284
Dopamine receptor antagonists induce differentiation of PC-3 human prostate cancer cell-derived cancer stem cell-like cells. 61
30816566 2019
285
Research Evidence on High-Fat Diet-Induced Prostate Cancer Development and Progression. 61
31052319 2019
286
Extracellular Fatty Acids Are the Major Contributor to Lipid Synthesis in Prostate Cancer. 61
30647103 2019
287
Coffee diterpenes kahweol acetate and cafestol synergistically inhibit the proliferation and migration of prostate cancer cells. 61
30569541 2019
288
MiR-10a functions as a tumor suppressor in prostate cancer via targeting KDM4A. 61
30302800 2019
289
miR-500 promotes cell proliferation by directly targetting LRP1B in prostate cancer. 61
30877185 2019
290
Cell-based evidence regarding the role of FSH in prostate cancer. 61
30611646 2019
291
Local Injection of Submicron Particle Docetaxel is Associated with Tumor Eradication, Reduced Systemic Toxicity and an Immunologic Response in Uro-Oncologic Xenografts. 61
31022918 2019
292
Synthesis of Pyridine-Dicarboxamide-Cyclohexanone Derivatives: Anticancer and α-Glucosidase Inhibitory Activities and In Silico Study. 61
30987350 2019
293
CYP enzymes, expressed within live human suspension cells, are superior to widely-used microsomal enzymes in identifying potent CYP1A1/CYP1B1 inhibitors: Identification of quinazolinones as CYP1A1/CYP1B1 inhibitors that efficiently reverse B[a]P toxicity and cisplatin resistance. 61
30776468 2019
294
Endoplasmic reticulum stress, autophagic and apoptotic cell death, and immune activation by a natural triterpenoid in human prostate cancer cells. 61
30378157 2019
295
Identification of Further Components of an Anticancer Defense System Composed of Small Molecules Present in the Serum. 61
30648878 2019
296
Identification of dehydroxy isoquine and isotebuquine as promising anticancer agents targeting K+ channel. 61
30570823 2019
297
Design, Synthesis, and Evaluation of Monoamine Oxidase A Inhibitors⁻Indocyanine Dyes Conjugates as Targeted Antitumor Agents. 61
30974737 2019
298
A Useful Synthesis of 2-Acylamino-1,3,4-oxadiazoles from Acylthiosemicarbazides Using Potassium Iodate and the Discovery of New Antibacterial Compounds. 61
30988267 2019
299
Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells. 61
30844609 2019
300
Quinazolin-4(3H)-one-Based Hydroxamic Acids: Design, Synthesis and Evaluation of Histone Deacetylase Inhibitory Effects and Cytotoxicity. 61
30653817 2019
301
Facile development, characterization, and evaluation of novel bicalutamide loaded pH-sensitive mesoporous silica nanoparticles for enhanced prostate cancer therapy. 61
30582382 2019
302
Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice. 61
30779980 2019
303
Cytotoxic constituents from Penicillium concentricum, an endophytic fungus from Trichocolea tomentella. 61
30688672 2019
304
Conolodinines A-D, Aspidosperma- Aspidosperma Bisindole Alkaloids with Antiproliferative Activity from Tabernaemontana corymbosa. 61
30869890 2019
305
Rho-Associated Protein Kinase (ROCK) Promotes Proliferation and Migration of PC-3 and DU145 Prostate Cancer Cells by Targeting LIM Kinase 1 (LIMK1) and Matrix Metalloproteinase-2 (MMP-2). 61
31026254 2019
306
Cytotoxic Prenylated Xanthones from the Leaves of Garcinia bracteata. 61
30650454 2019
307
Stereocontrolled Synthesis of Bispirooxindole-Based Hexahydroxanthones with Five Contiguous Stereocenters. 61
30925061 2019
308
ABT-737 and erufosine combination against castration-resistant prostate cancer: a promising but cell-type specific response associated with the modulation of anti-apoptotic signaling. 61
30557204 2019
309
Design, synthesis and activity evaluation of indole-based double - Branched HDAC1 inhibitors. 61
30879863 2019
310
Click chemistry-based synthesis and cytotoxic activity evaluation of 4α-triazole acetate podophyllotoxin derivatives. 61
30394007 2019
311
Novel Gastrin-Releasing Peptide Receptor Targeted Near-Infrared Fluorescence Dye for Image-Guided Surgery of Prostate Cancer. 61
31025163 2019
312
Synthesis, anti-proliferative and apoptosis-inducing studies of palladacycles containing a diphosphine and a Sn,As-based chelate ligand. 61
30838370 2019
313
Synthesis, computational quantum chemical study, in silico ADMET and molecular docking analysis, in vitro biological evaluation of a novel sulfur heterocyclic thiophene derivative containing 1,2,3-triazole and pyridine moieties as a potential human topoisomerase IIα inhibiting anticancer agent. 61
30731361 2019
314
Precise Modeling of the Protective Effects of Quercetin against Mycotoxin via System Identification with Neural Networks. 61
30965553 2019
315
Purines Change at Acupoints along the Pericardium Meridian in Healthy and Myocardial Ischemic Rats. 61
30264268 2019
316
Oxytrodiflavanone A and Oxytrochalcoflavanones A,B: New Biflavonoids from Oxytropis chiliophylla. 61
31013944 2019
317
Dokdolipids A-C, Hydroxylated Rhamnolipids from the Marine-Derived Actinomycete Actinoalloteichus hymeniacidonis. 61
31010028 2019
318
Antiproliferative and antibiofilm potentials of endolichenic fungi associated with the lichen Nephroma laevigatum. 61
30597735 2019
319
Synthesis and antiproliferative evaluation of new zampanolide mimics. 61
30924817 2019
320
The Anti-Proliferation, Cycle Arrest and Apoptotic Inducing Activity of Peperomin E on Prostate Cancer PC-3 Cell Line. 61
30991627 2019
321
Salinomycin triggers endoplasmic reticulum stress through ATP2A3 upregulation in PC-3 cells. 61
31023247 2019
322
Semisynthetic aurones inhibit tubulin polymerization at the colchicine-binding site and repress PC-3 tumor xenografts in nude mice and myc-induced T-ALL in zebrafish. 61
31015569 2019
323
Mechanism of LncRNA ROR promoting prostate cancer by regulating Akt. 61
30915739 2019
324
Ent-Dihydrotucumanoic acid promotes apoptosis in PC-3 human prostate cancer cells. 61
30942164 2019
325
Tumor-Penetrating Peptide Enhances Antitumor Effects of IL-24 Against Prostate Cancer. 61
30580153 2019
326
Radiopotentiation of enzalutamide over human prostate cancer cells as assessed by real-time cell monitoring. 61
30858765 2019
327
Calcilytics inhibit the proliferation and migration of human prostate cancer PC-3 cells. 61
30808588 2019
328
The WNT/β-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro. 61
30886380 2019
329
Overexpressed LRIG3 gene ameliorates prostate cancer through suppression of cell invasion and migration. 61
30412760 2019
330
Fomes fomentarius Ethanol Extract Exerts Inhibition of Cell Growth and Motility Induction of Apoptosis via Targeting AKT in Human Breast Cancer MDA-MB-231 Cells. 61
30845749 2019
331
Quantitative immunohistochemical assay with novel digital immunostaining for comparisons of PD-L1 antibodies. 61
30847180 2019
332
Design, Synthesis, and Molecular Docking Study of Novel Heterocycles Incorporating 1,3,4-Thiadiazole Moiety as Potential Antimicrobial and Anticancer Agents. 61
30889918 2019
333
CD44 Promotes Migration and Invasion of Docetaxel-Resistant Prostate Cancer Cells Likely via Induction of Hippo-Yap Signaling. 61
30935014 2019
334
Antidiarrheal, Analgesic, and Anthelmintic Activities of Honeys in the Sundarbans Mangrove Forest, Bangladesh. 61
31008096 2019
335
MiR-93 functions as a tumor promoter in prostate cancer by targeting disabled homolog 2 (DAB2) and an antitumor polysaccharide from green tea (Camellia sinensis) on their expression. 61
30543885 2019
336
Design, synthesis and molecular modeling study of certain VEGFR-2 inhibitors based on thienopyrimidne scaffold as cancer targeting agents. 61
30343204 2019
337
Sox7 negatively regulates prostate-specific membrane antigen (PSMA) expression through PSMA-enhancer. 61
30488457 2019
338
RAD9A promotes metastatic phenotypes through transcriptional regulation of anterior gradient 2 (AGR2). 61
30295739 2019
339
[Citron Rho-interacting serine/threonine kinase knockdown suppresses prostate cancer cell proliferation and metastasis by blocking Hippo-YAP pathway]. 61
31068310 2019
340
Quantification of Cell Death Using an Impedance-Based Microfluidic Device. 61
30793881 2019
341
Localization of 99mTc-GRP Analogs in GRPR-Expressing Tumors: Effects of Peptide Length and Neprilysin Inhibition on Biological Responses. 61
30897789 2019
342
Comparing Gly11/dAla11-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the 111In-SB3/111In-SB4 Radiotracer Pair. 61
30871262 2019
343
In vitro antioxidant and antiproliferative effect of the extracts of Ephedra chilensis K Presl aerial parts. 61
30832627 2019
344
Chemical composition, antioxidant, antimicrobial and anticancer activities of the essential oil from the rhizomes of Zingiber striolatum Diels. 61
30908095 2019
345
Structure-Based Design of Novel Benzimidazole Derivatives as Pin1 Inhibitors. 61
30934730 2019
346
Stereocontrolled [3+2] Cycloaddition of Donor-Acceptor Cyclopropanes to Iminooxindoles: Access to Spiro[oxindole-3,2'-pyrrolidines]. 61
30735387 2019
347
Serum promotes vasculogenic mimicry through the EphA2/VE-cadherin/AKT pathway in PC-3 human prostate cancer cells. 61
30797819 2019
348
The determination of the potential anticancer effects of Coriandrum sativum in PC-3 and LNCaP prostate cancer cell lines. 61
30417420 2019
349
miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibition. 61
30717752 2019
350
MicroRNA-30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHRM3. 61
30483762 2019
351
Lack of combination effects of soy isoflavones and taxane chemotherapy of castration-resistant prostate cancer. 61
30345530 2019
352
miR-615 Inhibits Prostate Cancer Cell Proliferation and Invasion by Directly Targeting Cyclin D2. 61
29471894 2019
353
The BET-inhibitor PFI-1 diminishes AR/AR-V7 signaling in prostate cancer cells. 61
29934670 2019
354
αvβ3 Integrin Mediates Radioresistance of Prostate Cancer Cells through Regulation of Survivin. 61
30266752 2019
355
Anti-tumor activity and the mechanism of a green tea (Camellia sinensis) polysaccharide on prostate cancer. 61
30342140 2019
356
Reduced Arginyltransferase 1 is a driver and a potential prognostic indicator of prostate cancer metastasis. 61
30177837 2019
357
Butyl benzyl phthalate promotes prostate cancer cell proliferation through miR-34a downregulation. 61
30243731 2019
358
SWATH proteomic profiling of prostate cancer cells identifies NUSAP1 as a potential molecular target for Galiellalactone. 61
30626528 2019
359
Correlation of SOX9 and NM23 genes with the incidence and prognosis of prostate cancer. 61
30675295 2019
360
Trabectedin Reduces Skeletal Prostate Cancer Tumor Size in Association with Effects on M2 Macrophages and Efferocytosis. 61
30591422 2019
361
Hypoxia Patterns in Primary and Metastatic Prostate Cancer Environments. 61
30639975 2019
362
Synthesis of new thiazolo-pyrrolidine-(spirooxindole) tethered to 3-acylindole as anticancer agents. 61
30508794 2019
363
Chlorambucil Conjugated Ugi Dendrimers with PAMAM-NH₂ Core and Evaluation of Their Anticancer Activity. 61
30717083 2019
364
Bioactive staurosporine derivatives from the Streptomyces sp. NB-A13. 61
30268972 2019
365
Effect of Compatibility on the Foaming Behavior of Injection Molded Polypropylene and Polycarbonate Blend Parts. 61
30960284 2019
366
DGAT1 Inhibitor Suppresses Prostate Tumor Growth and Migration by Regulating Intracellular Lipids and Non-Centrosomal MTOC Protein GM130. 61
30816200 2019
367
Design, synthesis and biological evaluation of novel 7-amino-[1,2,4]triazolo[4,3-f]pteridinone, and 7-aminotetrazolo[1,5-f]pteridinone derivative as potent antitumor agents. 61
30572179 2019
368
In vivo comparison of the proangiogenic properties of chlordecone and three of its dechlorinated derivatives formed by in situ chemical reduction. 61
30710326 2019
369
Iterative unsupervised domain adaptation for generalized cell detection from brightfield z-stacks. 61
30767778 2019
370
Cytotoxic triterpenoid saponins from the root of Anemone tomentosa (Maxim.) Pei. 61
30810364 2019
371
Lactoquinomycin C and D, two new medermycin derivatives from the marine-derived Streptomyces sp. SS17A. 61
30806517 2019
372
Synthesis of new chalcone-based homoserine lactones and their antiproliferative activity evaluation. 61
30553142 2019
373
Development of Novel Anticancer Agents with a Scaffold of Tetrahydropyrido[4,3-d]pyrimidine-2,4-dione. 61
30783502 2019
374
Bioactive scalemic caged xanthones from the leaves of Garcinia bracteata. 61
30396061 2019
375
The human oncogene SCL/TAL1 interrupting locus (STIL) promotes tumor growth through MAPK/ERK, PI3K/Akt and AMPK pathways in prostate cancer. 61
30453068 2019
376
An irreversible inhibitor of peptidyl-prolyl cis/trans isomerase Pin1 and evaluation of cytotoxicity. 61
30585173 2019
377
Development of alkyl glycerone phosphate synthase inhibitors: Structure-activity relationship and effects on ether lipids and epithelial-mesenchymal transition in cancer cells. 61
30576903 2019
378
Design and synthesis of new substituted pyrazolopyridines with potent antiproliferative activity. 61
30799794 2019
379
Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancer. 61
30554119 2019
380
Synthesis and Antibacterial Activity of Mefloquine-Based Analogs Against Sensitive and Resistant Mycobacterium tuberculosis Strains. 61
30836914 2019
381
Precooling, Exertional Heatstroke Risk Factors, and Postexercise Cooling Rates. 61
30579372 2019
382
[Lipid metabolism study of sodium norcantharidate in LO2 hepatocytes based on lipidomics]. 61
30868827 2019
383
Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling. 61
31534537 2019
384
Extracellular Electrophysiology in the Prostate Cancer Cell Model PC-3. 61
30609788 2019
385
Bioconjugated Gold Nanoparticles Enhance siRNA Delivery in Prostate Cancer Cells. 61
31099011 2019
386
HIF1α promotes prostate cancer progression by increasing ATG5 expression. 61
31700698 2019
387
Bloom Syndrome Protein Activates AKT and PRAS40 in Prostate Cancer Cells. 61
31210839 2019
388
Downregulation of DACT-2 by Promoter Methylation and its Clinicopathological Significance in Prostate Cancer. 61
31205531 2019
389
MCT4 promotes cell proliferation and invasion of castration-resistant prostate cancer PC-3 cell line. 61
31217781 2019
390
SPAG9 promotes prostate cancer proliferation and metastasis via MAPK signaling pathway. 61
31497238 2019
391
Targeting prostate cancer cell proliferation, stemness and metastatic potential using Costus speciosus derived phytochemicals. 61
31105862 2019
392
Inhibition of Prostate Cancer Cells by 4,5-Dicaffeoylquinic Acid through Cell Cycle Arrest. 61
31263600 2019
393
The Effects of Matrine in Combination with Docetaxel on Castration-Resistant (Androgen-Independent) Prostate Cancer. 61
31819645 2019
394
Immuno-PET imaging of VEGFR-2 expression in prostate cancer with 89Zr-labeled ramucirumab. 61
31598404 2019
395
Evaluation of A Novel GLP-1R Ligand for PET Imaging of Prostate Cancer. 61
30068284 2019
396
Synthesis and biological evaluation of arylpiperazine derivatives as potential anti-prostate cancer agents. 61
30482547 2019
397
Galectin-9 induces atypical ubiquitination leading to cell death in PC-3 prostate cancer cells. 61
30383222 2019
398
CircHIPK3 overexpression accelerates the proliferation and invasion of prostate cancer cells through regulating miRNA-338-3p. 61
31118688 2019
399
In Vivo 3D MRI Measurement of Tumour Volume in an Orthotopic Mouse Model of Prostate Cancer. 61
31032634 2019
400
Synergistic Effects of Nobiletin and Sorafenib Combination on Metastatic Prostate Cancer Cells. 61
31037974 2019
401
Herceptin-conjugated liposomes co-loaded with doxorubicin and simvastatin in targeted prostate cancer therapy. 61
30972160 2019
402
Class IIb HDAC Inhibition Enhances the Inhibitory Effect of Am80, a Synthetic Retinoid, in Prostate Cancer. 61
30828077 2019
403
Inhibition of miR-9-5p suppresses prostate cancer progress by targeting StarD13. 61
30899277 2019
404
Tumor-Specific S/G2-Phase Cell Cycle Arrest of Cancer Cells by Methionine Restriction. 61
30725407 2019
405
Pirfenidone, an Anti-Fibrotic Drug, Suppresses the Growth of Human Prostate Cancer Cells by Inducing G₁ Cell Cycle Arrest. 61
30621175 2019
406
PC-3-Derived Exosomes Inhibit Osteoclast Differentiation by Downregulating miR-214 and Blocking NF-κB Signaling Pathway. 61
31058194 2019
407
Histone Deacetylase Inhibitor Modulates NKG2D Receptor Expression and Memory Phenotype of Human Gamma/Delta T Cells Upon Interaction With Tumor Cells. 61
30972064 2019
408
miR-106a contributes to prostate carcinoma progression through PTEN. 61
30655902 2019
409
Antitumoral and Anticholinesterasic Activities of the Seven Species from Rubiaceae. 61
30747062 2019
410
Cytotoxic and Apoptotic Activity of Majoranolide from Mezilaurus crassiramea on HL-60 Leukemia Cells. 61
30941193 2019
411
Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells. 61
30669516 2019
412
Knockdown of PTOV1 and PIN1 exhibit common phenotypic anti-cancer effects in MDA-MB-231 cells. 61
31083670 2019
413
UPLC-ESI-PDA-Msn Profiling Of Phenolics Involved In Biological Activities Of The Medicinal Plant Halocnemum Strobilaceum (Pall.). 61
31089377 2019
414
In-vitro Morphological Assessment of Apoptosis Induced by Nimbolide; A Limonoid from Azadirachta Indica (Neem Tree). 61
31531067 2019
415
Graphene-based hybrid nanoparticle of doxorubicin for cancer chemotherapy. 61
31686814 2019
416
Design, Synthesis, and Biological Evaluation of (E)-N'-((1-Chloro-3,4-Dihydronaphthalen-2-yl)Methylene)Benzohydrazide Derivatives as Anti-prostate Cancer Agents. 61
31355179 2019
417
A chemoenzymatically synthesized cholesterol-g-poly(amine-co-ester)-mediated p53 gene delivery for achieving antitumor efficacy in prostate cancer. 61
30863051 2019
418
Synthesis of a tubugi-1-toxin conjugate by a modulizable disulfide linker system with a neuropeptide Y analogue showing selectivity for hY1R-overexpressing tumor cells. 61
30680044 2019
419
The anti-apoptotic proteins NAF-1 and iASPP interact to drive apoptosis in cancer cells. 61
30774867 2019
420
Design, synthesis and anti-tumor evaluation of novel steroidal glycoconjugate with furoxan derivatives. 61
30521816 2019
421
Synthesis and SAR of novel capsazepine analogs with significant anti-cancer effects in multiple cancer types. 61
30528162 2019
422
Codelivery of GRP78 siRNA and docetaxel via RGD-PEG-DSPE/DOPA/CaP nanoparticles for the treatment of castration-resistant prostate cancer. 61
31118572 2019
423
Metabolic signature of extracellular vesicles depends on the cell culture conditions. 61
31007875 2019
424
MicroRNA-4719 and microRNA-6756-5p Correlate with Castration-Resistant Prostate Cancer Progression through Interleukin-24 Regulation. 61
30669553 2019
425
Synthesis of Oridonin Derivatives via Mizoroki-Heck Reaction and Click Chemistry for Cytotoxic Activity. 61
30657049 2019
426
Development of resveratrol-conjugated gold nanoparticles: interrelationship of increased resveratrol corona on anti-tumor efficacy against breast, pancreatic and prostate cancers. 61
31417252 2019
427
Eya2 Is Overexpressed in Human Prostate Cancer and Regulates Docetaxel Sensitivity and Mitochondrial Membrane Potential through AKT/Bcl-2 Signaling. 61
31317026 2019
428
Long non-coding RNA CCAT1/miR-148a/PKCζ prevents cell migration of prostate cancer by altering macrophage polarization. 61
30221381 2019
429
Synthesis and Biological Evaluation of Novel 4,5,6,7-Tetrahydrobenzo[D]-Thiazol-2- Yl Derivatives Derived from Dimedone with Anti-Tumor, C-Met, Tyrosine Kinase and Pim-1 Inhibitions. 61
31038076 2019
430
Cross Sectional Study and Risk Factors Analysis of Francisella tularensis in Soil Samples in Punjab Province of Pakistan. 61
31024860 2019
431
Positron Emission Tomography Imaging of the Gastrin-Releasing Peptide Receptor with a Novel Bombesin Analogue. 61
30775647 2019
432
Tumor targeting with DGEA peptide ligands: a new aromatic peptide amphiphile for imaging cancers. 61
30617356 2019
433
Synthesis of D-Ring Annulated Pyridosteroids from β-Formyl Enamides and Their Biological Evaluations. 61
30576125 2019
434
New depsidone and dichromone from the stems of Garcinia paucinervis with antiproliferative activity. 61
30182180 2019
435
Induction of apoptosis and modulation of homologous recombination DNA repair pathway in prostate cancer cells by the combination of AZD2461 and valproic acid. 61
31423128 2019
436
Mesenchymal Stem Cell Isolation from Pulp Tissue and Co-Culture with Cancer Cells to Study Their Interactions. 61
30663693 2019
437
Muscadine grape skin extract inhibits prostate cancer cells by inducing cell-cycle arrest, and decreasing migration through heat shock protein 40. 61
30705983 2019
438
Unfolded Protein Response is Involved in Trans-Platinum (II) Complex-Induced Apoptosis in Prostate Cancer Cells via ROS Accumulation. 61
30963984 2019
439
Design, synthesis and QSAR study of 2'-hydroxy-4'-alkoxy chalcone derivatives that exert cytotoxic activity by the mitochondrial apoptotic pathway. 61
30482548 2019
440
Development of anisamide-targeted PEGylated gold nanorods to deliver epirubicin for chemo-photothermal therapy in tumor-bearing mice. 61
30880982 2019
441
Pim-2 Cooperates with Downstream Factor XIAP to Inhibit Apoptosis and Intensify Malignant Grade in Prostate Cancer. 61
29124675 2019
442
Cytotoxic xanthones from the roots of Mesua ferrea L. 61
30368220 2019
443
A new xanthyletin-type coumarin from the roots of Peucedanum praeruptorum. 61
30621449 2019
444
Upregulation of Circular RNA Itchy E3 Ubiquitin Protein Ligase Inhibits Cell Proliferation and Promotes Cell Apoptosis Through Targeting MiR-197 in Prostate Cancer. 61
31694481 2019
445
MiR-1299 functions as a tumor suppressor to inhibit the proliferation and metastasis of prostate cancer by targeting NEK2. 61
30720160 2019
446
Prostate cancer cell growth characteristics in serum and prostate-conditioned media from moderate-intensity exercise-trained healthy and tumor-bearing rats. 61
31105994 2019
447
The Combination of Metformin and Valproic Acid Has a Greater Anti-tumoral Effect on Prostate Cancer Growth In Vivo than Either Drug Alone. 61
30587609 2019
448
Bioactive contents, In vitro antiradical, antimicrobial and cytotoxic properties of rhubarb (Rheum ribes L.) extracts. 61
30663386 2019
449
Synthesis and Evaluation of 18F-Labeled Peptide for Gonadotropin-Releasing Hormone Receptor Imaging. 61
30983920 2019
450
Evaluating the biological properties of synthetic 4-nitrophenyl functionalized benzofuran derivatives with telomeric DNA binding and antiproliferative activities. 61
30261256 2019
451
A pair of new enantiomers of xanthones from the stems and leaves of Cratoxylum cochinchinense. 61
30976295 2019
452
Design, Synthesis and Biological Evaluation of 4-Aryl-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one Derivatives as a PI3Kα Inhibitor. 61
31155575 2019
453
Development of Promising Thiopyrimidine-Based Anti-cancer and Antimicrobial Agents: Synthesis and QSAR Analysis. 61
29600761 2019
454
In Vivo Stabilized SB3, an Attractive GRPR Antagonist, for Pre- and Intra-Operative Imaging for Prostate Cancer. 61
29556947 2018
455
Isoalantolactone induces apoptosis through ROS-mediated ER stress and inhibition of STAT3 in prostate cancer cells. 61
30541589 2018
456
Naringenin Attenuated Prostate Cancer Invasion via Reversal of Epithelial-to-Mesenchymal Transition and Inhibited uPA Activity. 61
30504386 2018
457
Expression of FGD4 positively correlates with the aggressive phenotype of prostate cancer. 61
30558664 2018
458
A novel selenonucleoside suppresses tumor growth by targeting Skp2 degradation in paclitaxel-resistant prostate cancer. 61
30292755 2018
459
Targeted regulation of miR-195 on MAP2K1 for suppressing ADM drug resistance in prostate cancer cells. 61
30575899 2018
460
Repurposing antitubercular agent isoniazid for treatment of prostate cancer. 61
30468220 2018
461
Synthesis, antitumour and antioxidant activities of novel α,β-unsaturated ketones and related heterocyclic analogues: EGFR inhibition and molecular modelling study. 61
29455554 2018
462
Multifunctional antioxidant nanoliposome-mediated delivery of PTEN plasmids restore the expression of tumor suppressor protein and induce apoptosis in prostate cancer cells. 61
30194716 2018
463
Low Molecular Weight Mannogalactofucans Derived from Undaria pinnatifida Induce Apoptotic Death of Human Prostate Cancer Cells In Vitro and In Vivo. 61
30159630 2018
464
A novel antimicrobial peptide, Ranatuerin-2PLx, showing therapeutic potential in inhibiting proliferation of cancer cells. 61
30279210 2018
465
Optical study of chemotherapy efficiency in cancer treatment via intracellular structural disorder analysis using partial wave spectroscopy. 61
29869394 2018
466
Redox-sensitive, cholesterol-bearing PEGylated poly(propylene imine)-based dendrimersomes for drug and gene delivery to cancer cells. 61
30488937 2018
467
Addressable TiO2 Nanotubes Functionalized Paper-Based Cyto-Sensor with Photocontrollable Switch for Highly-Efficient Evaluating Surface Protein Expressions of Cancer Cells. 61
30277055 2018
468
Distribution, Sources, and Water Quality Assessment of Dissolved Heavy Metals in the Jiulongjiang River Water, Southeast China. 61
30563145 2018
469
Characterization of ankaflavin from Penicillium aculeatum and its cytotoxic properties. 61
30587035 2018
470
Potential of piperine in modulation of voltage-gated K+ current and its influences on cell cycle arrest and apoptosis in human prostate cancer cells. 61
30575945 2018
471
Synthesis and antiproliferative activity of 17-[1',2',3']-selenadiazolylpregnenolone compounds. 61
30296550 2018
472
Anticancer evaluation and molecular modeling of multi-targeted kinase inhibitors based pyrido[2,3-d]pyrimidine scaffold. 61
29482389 2018
473
A stent film of paclitaxel presenting extreme accumulation of paclitaxel in tumor tissue and excellent antitumor efficacy after implantation beneath the subcutaneous tumor xenograft in mice. 61
30267754 2018
474
Synthesis and in vitro antitumor evaluation of some new thiophenes and thieno[2,3-d]pyrimidine derivatives. 61
30248510 2018
475
4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides Selectively Target the Tumor-Associated Carbonic Anhydrase Isoforms IX and XII Showing Hypoxia-Enhanced Antiproliferative Profiles. 61
30433782 2018
476
Straightforward synthesis, characterization, and cytotoxicity evaluation of hybrids of natural alkaloid evodiamine/rutaecarpine and thieno[2,3-d]pyrimidinones. 61
30588834 2018
477
Design and Preclinical Evaluation of an Albumin-Binding PSMA Ligand for 64Cu-Based PET Imaging. 61
30376344 2018
478
[Data-mining-revealed Regularities of Application of Meridian Acupoints for Coronary Heart Disease in Ancient Chinese Medical Literature]. 61
30585460 2018
479
Effects of non-steroidal anti-inflammatory drug-activated gene-1 on Ganoderma lucidum polysaccharides-induced apoptosis of human prostate cancer PC-3 cells. 61
30272272 2018
480
Retraction Note: Umbilical cord tissue-derived mesenchymal stem cells induce apoptosis in PC-3 prostate cancer cells through activation of JNK and downregulation of PI3K/AKT signaling. 61
30587247 2018
481
Design, synthesis, ADME prediction and pharmacological evaluation of novel benzimidazole-1,2,3-triazole-sulfonamide hybrids as antimicrobial and antiproliferative agents. 61
30387018 2018
482
Volatile Profiling, Insecticidal, Antibacterial and Antiproliferative Properties of the Essential Oils of Bursera glabrifolia Leaves. 61
30187618 2018
483
PSMA Antibody-Conjugated Pentablock Copolymer Nanomicellar Formulation for Targeted Delivery to Prostate Cancer. 61
30151731 2018
484
Effects of 3-butenyl isothiocyanate on phenotypically different prostate cancer cells. 61
30226593 2018
485
Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo. 61
30419852 2018
486
Muscarinic acetylcholine receptor M1 mediates prostate cancer cell migration and invasion through hedgehog signaling. 61
30027929 2018
487
Glutathione/pH-responsive nanosponges enhance strigolactone delivery to prostate cancer cells. 61
30533197 2018
488
O-Aminoalkyl-O-Trimethyl-2,3-Dehydrosilybins: Synthesis and In Vitro Effects Towards Prostate Cancer Cells. 61
30501133 2018
489
[Expression of forkhead transcription factor O4 in prostate cancer and its effect on prostate cancer cell invasion]. 61
30643063 2018
490
Mechanistic insights of epithelial protein lost in neoplasm in prostate cancer metastasis. 61
30098000 2018
491
Cytotoxicity of AMANTADIG - a semisynthetic digitoxigenin derivative - alone and in combination with docetaxel in human hormone-refractory prostate cancer cells and its effect on Na+/K+-ATPase inhibition. 61
30107342 2018
492
Arctigenin shows preferential cytotoxicity to acidity-tolerant prostate carcinoma PC-3 cells through ROS-mediated mitochondrial damage and the inhibition of PI3K/Akt/mTOR pathway. 61
30333093 2018
493
A novel role and mechanism of cystic fibrosis transmembrane conductance regulator in bisphenol A-induced prostate cancer. 61
30485539 2018
494
Diverse effects of phospholipase A2 receptor expression on LNCaP and PC-3 prostate cancer cell growth in vitro and in vivo. 61
30542512 2018
495
Synthesis and anticancer activity of novel rapamycin C-28 containing triazole moiety compounds. 61
30357890 2018
496
Highly Cancer Selective Antiproliferative Activity of Natural Prenylated Flavonoids. 61
30423918 2018
497
7,8-Dihydroxy-3-arylcoumarin Induces Cell Death Through S-Phase Arrest in MDA-MB-231 Breast Cancer Cells. 61
30396923 2018
498
Disease-directed design of biodegradable polymers: Reactive oxygen species and pH-responsive micellar nanoparticles for anticancer drug delivery. 61
30017961 2018
499
Clickable conjugates of bile acids and nucleosides: Synthesis, characterization, in vitro anticancer and antituberculosis studies. 61
30236620 2018
500
GC-MS Characterization of Volatile Flavor Compounds in Stinky Tofu Brine by Optimization of Headspace Solid-Phase Microextraction Conditions. 61
30513662 2018
501
Synthesis and cytotoxic activity of 4-O-β-D-galactopyranosyl derivatives of phenolic acids esters. 61
28920447 2018
502
Glucose-installed biodegradable polymeric micelles for cancer-targeted drug delivery system: synthesis, characterization and in vitro evaluation. 61
30506149 2018
503
Synthesis and pharmacological evaluation of novel epidermal growth factor receptor inhibitors against prostate tumor cells. 61
30405791 2018
504
A new phenolic compound from Phedimus middendorffianus with antiproliferative activity. 61
30470138 2018
505
Preliminary evaluation of a novel 18F-labeled PARP-1 ligand for PET imaging of PARP-1 expression in prostate cancer. 61
30195072 2018
506
Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-α, TRAIL, and interleukin-12. 61
29493296 2018
507
Rosmarinic Acid, a Component of Rosemary Tea, Induced the Cell Cycle Arrest and Apoptosis through Modulation of HDAC2 Expression in Prostate Cancer Cell Lines. 61
30453545 2018
508
Synthesis and Biological Evaluation of Phaeosphaeride A Derivatives as Antitumor Agents. 61
30469343 2018
509
MicroRNA-23b and microRNA-27b plus flutamide treatment enhances apoptosis rate and decreases CCNG1 expression in a castration-resistant prostate cancer cell line. 61
30400755 2018
510
Synthesis of Triazole-Substituted Quinazoline Hybrids for Anticancer Activity and a Lead Compound as the EGFR Blocker and ROS Inducer Agent. 61
30556027 2018
511
Kinase Inhibitory Activities and Molecular Docking of a Novel Series of Anticancer Pyrazole Derivatives. 61
30477238 2018
512
2'‑Hydroxyflavanone inhibits epithelial‑mesenchymal transition, and cell migration and invasion via suppression of the Wnt/β‑catenin signaling pathway in prostate cancer. 61
30226607 2018
513
Monolayer grafting of aminosilane on magnetic nanoparticles: An efficient approach for targeted drug delivery system. 61
29940324 2018
514
Gold(i) and gold(iii) phosphine complexes: synthesis, anticancer activities towards 2D and 3D cancer models, and apoptosis inducing properties. 61
30187047 2018
515
Direct Transfection of Fatty Acid Conjugated siRNAs and Knockdown of the Glucose-Regulated Chaperones in Prostate Cancer Cells. 61
30235926 2018
516
Inhibition of atypical protein kinase C‑ι effectively reduces the malignancy of prostate cancer cells by downregulating the NF-κB signaling cascade. 61
30226591 2018
517
Apoptosis Induction of Agave lechuguilla Torrey Extract on Human Lung Adenocarcinoma Cells (SK-LU-1). 61
30486412 2018
518
18F‑alfatide positron emission tomography may predict anti‑angiogenic responses. 61
30226599 2018
519
Different Efflux Transporter Affinity and Metabolism of 99mTc-2-Methoxyisobutylisonitrile and 99mTc-Tetrofosmin for Multidrug Resistance Monitoring in Cancer. 61
30498970 2018
520
Consistent head up cardiopulmonary resuscitation haemodynamics are observed across porcine and human cadaver translational models. 61
29702188 2018
521
The impact of TRAIL on proliferation of secretory prostate cancer PC-3 cell and LMO2 gene expression. 61
30468458 2018
522
Parallel study on protein O-GlcNAcylation in prostate cancer cell with a sensitive microarray biochip. 61
30086259 2018
523
A natural molecule, urolithin A, downregulates androgen receptor activation and suppresses growth of prostate cancer. 61
30069922 2018
524
LPA1/3 signaling mediates tumor lymphangiogenesis through promoting CRT expression in prostate cancer. 61
30053596 2018
525
Correlation between DEC1/DEC2 and epithelial‑mesenchymal transition in human prostate cancer PC‑3 cells. 61
30106153 2018
526
Zinc enhances chemosensitivity to paclitaxel in PC‑3 prostate cancer cells. 61
30106439 2018
527
Structure-activity relationship of novel (benzoylaminophenoxy)phenol derivatives as anti-prostate cancer agents. 61
30228001 2018
528
Structure-based assessment and network analysis of targeting 14-3-3 proteins in prostate cancer. 61
30382885 2018
529
Cordyceps sinensis Promotes the Growth of Prostate Cancer Cells. 61
30273008 2018
530
Conjugates of 17-substituted testosterone and epitestosterone with pyropheophorbide a differing in the length of linkers. 61
30033342 2018
531
Peptide-Functionalized Hydrogel Cubes for Active Tumor Cell Targeting. 61
30169033 2018
532
N'-[(E)-Arylidene]-2-(2,3-dihydro-3-oxo-4H-1,4-benzoxazin-4-yl)-acetohydrazides: Synthesis and Evaluation of Caspase Activation Activity and Cytotoxicity. 61
30054973 2018
533
Biological properties and structural study of new aminoalkyl derivatives of benzimidazole and benzotriazole, dual inhibitors of CK2 and PIM1 kinases. 61
29966873 2018
534
Synthesis, characterization, DNA/HSA interactions and in vitro cytotoxic activities of two novel water-soluble copper(II) complexes with 1,3,5-triazine derivative ligand and amino acids. 61
30033272 2018
535
AKR1C3, a crucial androgenic enzyme in prostate cancer, promotes epithelial-mesenchymal transition and metastasis through activating ERK signaling. 61
30139661 2018
536
Development of 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and their salts as potent cytotoxic agents and topoisomerase I/IIα inhibitors. 61
30253887 2018
537
Design, synthesis and biological evaluation of ring A modified 11-keto-boswellic acid derivatives as Pin1 inhibitors with remarkable anti-prostate cancer activity. 61
30153964 2018
538
The effects of habitual foot strike patterns on Achilles tendon loading in female runners. 61
30243212 2018
539
Strategic Pentablock Copolymer Nanomicellar Formulation for Paclitaxel Delivery System. 61
30112614 2018
540
Cymbopogon citratus and Cymbopogon giganteus essential oils have cytotoxic effects on tumor cell cultures. Identification of citral as a new putative anti-proliferative molecule. 61
29501481 2018
541
Anticancer and antibacterial potential of Rhus punjabensis and CuO nanoparticles. 61
30320505 2018
542
PSMA-Oriented Target Delivery of Novel Anticancer Prodrugs: Design, Synthesis, and Biological Evaluations of Oligopeptide-Camptothecin Conjugates. 61
30347770 2018
543
Oncotoxic Properties of Serotonin Transporter Inhibitors and 5-HT1A Receptor Ligands. 61
30347827 2018
544
Troglitazone inhibits the migration and invasion of PC-3 human prostate cancer cells by upregulating E-cadherin and glutathione peroxidase 3. 61
30250621 2018
545
Pharmacomodulation on Gold-NHC complexes for anticancer applications - is lipophilicity the key point? 61
30099254 2018
546
Lipidomic profiling of extracellular vesicles derived from prostate and prostate cancer cell lines. 61
30193584 2018
547
5'-Chloro-2,2'-dihydroxychalcone and related flavanoids as treatments for prostate cancer. 61
30189396 2018
548
Structure-activity relationship and pharmacokinetic studies of 3-O-substitutedflavonols as anti-prostate cancer agents. 61
30165345 2018
549
Ultrasound‑targeted microbubble destruction‑mediated miR‑205 enhances cisplatin cytotoxicity in prostate cancer cells. 61
30066866 2018
550
Anticancer mechanism of Sinapic acid in PC-3 and LNCaP human prostate cancer cell lines. 61
29792952 2018
551
College Education on Dietary Supplements May Promote Responsible Use In Young Adults. 61
30252551 2018
552
Amino-Substituted 2,2'-Bipyridine Ligands as Fluorescent Indicators for ZnII and Applications for Fluorescence Imaging of Prostate Cells. 61
30051526 2018
553
Enhanced capture and release of circulating tumor cells using hollow glass microspheres with a nanostructured surface. 61
30160287 2018
554
Enhanced Photodynamic Anticancer Activities of Multifunctional Magnetic Nanoparticles (Fe₃O₄) Conjugated with Chlorin e6 and Folic Acid in Prostate and Breast Cancer Cells. 61
30217046 2018
555
Synthesis and biological evaluation of novel Jiyuan Oridonin A-1,2,3-triazole-azole derivatives as antiproliferative agents. 61
30193221 2018
556
Two New Chromone Glycosides from the Roots of Saposhnikovia divaricata. 61
29987893 2018
557
Fatty acid-binding protein 5 (FABP5) promotes lipolysis of lipid droplets, de novo fatty acid (FA) synthesis and activation of nuclear factor-kappa B (NF-κB) signaling in cancer cells. 61
29906613 2018
558
Histone Methyltransferase Setd7 Regulates Nrf2 Signaling Pathway by Phenethyl Isothiocyanate and Ursolic Acid in Human Prostate Cancer Cells. 61
29383876 2018
559
SERS-Based Quantification of Biomarker Expression at the Single Cell Level Enabled by Gold Nanostars and Truncated Aptamers. 61
30110153 2018
560
Corosolic acid, a natural triterpenoid, induces ER stress-dependent apoptosis in human castration resistant prostate cancer cells via activation of IRE-1/JNK, PERK/CHOP and TRIB3. 61
30176898 2018
561
Transcriptional repressor Kaiso promotes epithelial to mesenchymal transition and metastasis in prostate cancer through direct regulation of miR-200c. 61
29751044 2018
562
Proteomic analysis reveals that pheophorbide a-mediated photodynamic treatment inhibits prostate cancer growth by hampering GDP-GTP exchange of ras-family proteins. 61
29800714 2018
563
Mesenchymal stem cells up-regulate the invasive potential of prostate cancer cells via the eotaxin-3/CCR3 axis. 61
30029937 2018
564
[Design, synthesis and antiproliferative activity in cancer cells of novel dihydropyrazolyl and pyrazolyl artemisinin-phenyl ethers]. 61
30347929 2018
565
Design, Synthesis, and in Vitro and in Vivo Evaluation of High Affinity and Specificity Near-Infrared Fluorescent Bombesin Antagonists for Tumor Imaging. 61
30111088 2018
566
Synthesis and Antiproliferative Activity of New Cyclodiprenyl Phenols against Select Cancer Cell Lines. 61
30213053 2018
567
Medermycin-Type Naphthoquinones from the Marine-Derived Streptomyces sp. XMA39. 61
30209946 2018
568
Bakuchiol exhibits anti-metastasis activity through NF-κB cross-talk signaling with AR and ERβ in androgen-independent prostate cancer cells PC-3. 61
30236540 2018
569
Novel selenadiazole derivatives as selective antitumor and radical scavenging agents. 61
30071406 2018
570
Cytotoxic effect of Kalanchoe flammea and induction of intrinsic mitochondrial apoptotic signaling in prostate cancer cells. 61
29730133 2018
571
Diosmetin suppresses human prostate cancer cell proliferation through the induction of apoptosis and cell cycle arrest. 61
29767250 2018
572
Synthesis, Molecular Docking and Anticancer Activity of Diflunisal Derivatives as Cyclooxygenase Enzyme Inhibitors. 61
30082676 2018
573
Neutrophil Extracellular Traps as an Adhesion Substrate for Different Tumor Cells Expressing RGD-Binding Integrins. 61
30096958 2018
574
PepSAVI-MS reveals anticancer and antifungal cycloviolacins in Viola odorata. 61
29734037 2018
575
A Tumor Vascular-Targeted Interlocking Trimodal Nanosystem That Induces and Exploits Hypoxia. 61
30128230 2018
576
New phenophospholipids equipped with multi-functionalities: Regiospecific synthesis and characterization. 61
29621644 2018
577
Synthesis, pharmacological evaluation and docking studies of progesterone and testosterone derivatives as anticancer agents. 61
29772243 2018
578
Design, synthesis and biological evaluation of AKT inhibitors bearing a piperidin-4-yl appendant. 61
30151089 2018
579
NOVEL CELLULAR STAINING PROTOCOL AND ANTIPROLIFERATIVE EFFECT OF VERNONIA AMYGDALINA DELILE ON LUNG AND PROSTATE CANCER CELLS. 61
30246001 2018
580
Anti-prostate cancer activity of 8-hydroxyquinoline-2-carboxaldehyde-thiosemicarbazide copper complexes in vivo by bioluminescence imaging. 61
30006867 2018
581
Autophagy inhibition improves the chemotherapeutic efficacy of cruciferous vegetable-derived diindolymethane in a murine prostate cancer xenograft model. 61
29607466 2018
582
Salinomycin-induced autophagy blocks apoptosis via the ATG3/AKT/mTOR signaling axis in PC-3 cells. 61
29966607 2018
583
Nontoxic Glucomoringin-Isothiocyanate (GMG-ITC) Rich Soluble Extract Induces Apoptosis and Inhibits Proliferation of Human Prostate Adenocarcinoma Cells (PC-3). 61
30150582 2018
584
Application of Mixture Design Response Surface Methodology for Combination Chemotherapy in PC-3 Human Prostate Cancer Cells. 61
29884690 2018
585
Alendronate-induced disruption of actin cytoskeleton and inhibition of migration/invasion are associated with cofilin downregulation in PC-3 prostate cancer cells. 61
30220968 2018
586
CA916798 affects growth and metastasis of androgen-dependent prostate cancer cells. 61
30058677 2018
587
Long non-coding RNA LINP1 promotes the malignant progression of prostate cancer by regulating p53. 61
30058678 2018
588
MicroRNA-139-5P inhibits human prostate cancer cell proliferation by targeting Notch1. 61
29963147 2018
589
Design, synthesis and in vitro evaluation of heterobivalent peptidic radioligands targeting both GRP- and VPAC1-Receptors concomitantly overexpressed on various malignancies - Is the concept feasible? 61
29864700 2018
590
Cyclooxygenase-2 induces angiogenesis in pancreatic cancer mediated by prostaglandin E2. 61
29963167 2018
591
Aniline-Tetramic Acids from the Deep-Sea-Derived Fungus Cladosporium sphaerospermum L3P3 Cultured with the HDAC Inhibitor SAHA. 61
29985604 2018
592
Tailor-made pH-sensitive polyacrylic acid functionalized mesoporous silica nanoparticles for efficient and controlled delivery of anti-cancer drug Etoposide. 61
29412022 2018
593
Valproic acid induces three novel cytotoxic secondary metabolites in Diaporthe sp., an endophytic fungus from Datura inoxia Mill. 61
29759727 2018
594
High C-X-C motif chemokine 5 expression is associated with malignant phenotypes of prostate cancer cells via autocrine and paracrine pathways. 61
29749439 2018
595
Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial. 61
29718095 2018
596
Impact of Green Tea Catechin ECG and Its Synthesized Fluorinated Analogue on Prostate Cancer Cells and Stimulated Immunocompetent Cells. 61
29466808 2018
597
The fibroblast surface markers FAP, anti-fibroblast, and FSP are expressed by cells of epithelial origin and may be altered during epithelial-to-mesenchymal transition. 61
28383825 2018
598
Mycobacterial inactivation protein extraction protocol for matrix-assisted laser desorption ionization time-of-flight characterization of clinical isolates. 61
30198499 2018
599
Chemical constituents of the fermentative extracts of marine fungi Phoma sp. CZD-F11 and Aspergillus sp. CZD-F18 from Zhoushan Archipelago, China. 61
29082752 2018
600
Palmitoylated phosphodiester gapmer designs with albumin binding capacity and maintained in vitro gene silencing activity. 61
29800498 2018
601
Cytotoxic diterpene quinones from Salvia tebesana Bunge. 61
29772301 2018
602
Matched-pair, 86Y/90Y-labeled, bivalent RGD/bombesin antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], as a potential theranostic agent for prostate cancer. 61
29929115 2018
603
DUSP1 is involved in the progression of small cell carcinoma of the prostate. 61
30108432 2018
604
Triterpenoids from Ziziphus jujuba induce apoptotic cell death in human cancer cells through mitochondrial reactive oxygen species production. 61
29968885 2018
605
Design, synthesis and biological evaluation of benzimidazole-rhodanine conjugates as potent topoisomerase II inhibitors. 61
30109008 2018
606
Asperindoles A⁻D and a p-Terphenyl Derivative from the Ascidian-Derived Fungus Aspergillus sp. KMM 4676. 61
29987238 2018
607
Metformin combined with quercetin synergistically repressed prostate cancer cells via inhibition of VEGF/PI3K/Akt signaling pathway. 61
29678660 2018
608
Optimized synthesis and antiproliferative activity of desTHPdactylolides. 61
29784275 2018
609
The ethanol extraction of prepared Psoralea corylifolia induces apoptosis and autophagy and alteres genes expression assayed by cDNA microarray in human prostate cancer PC-3 cells. 61
29667321 2018
610
Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12. 61
29633510 2018
611
The pharmacological properties of Ophiocordyceps xuefengensis revealed by transcriptome analysis. 61
29481852 2018
612
[Inhibitory effect of Qilan Capsules on the expressions of vasculogenic mimicry-related proteins in prostate cancer]. 61
30173460 2018
613
Nicotinamide N-methyltransferase enhances the progression of prostate cancer by stabilizing sirtuin 1. 61
29805651 2018
614
Frosted Slides Decorated with Silica Nanowires for Detecting Circulating Tumor Cells from Prostate Cancer Patients. 61
29770688 2018
615
A screening of growth inhibitory activity of Iranian medicinal plants on prostate cancer cell lines. 61
29806586 2018
616
4-Fluorobenzaldehyde limonene-based thiosemicarbazone induces apoptosis in PC-3 human prostate cancer cells. 61
29674122 2018
617
Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways. 61
29898731 2018
618
Lower endogenous p53 levels and degradation of AKT protein contribute to potent suppression of the new antibiotic Xiakemycin A on tumor cells. 61
29693151 2018
619
Inhibition of ANO1/TMEM16A induces apoptosis in human prostate carcinoma cells by activating TNF-α signaling. 61
29899325 2018
620
Quinazoline-Based Hydroxamic Acids: Design, Synthesis, and Evaluation of Histone Deacetylase Inhibitory Effects and Cytotoxicity. 61
29667768 2018
621
Chitosan (CMD)-mediated co-delivery of SN38 and Snail-specific siRNA as a useful anticancer approach against prostate cancer. 61
29626645 2018
622
The Use of Human, Bovine, and Camel Milk Albumins in Anticancer Complexes with Oleic Acid. 61
29691701 2018
623
Osteolytic cancer cells induce vascular/axon guidance processes in the bone/bone marrow stroma. 61
29988965 2018
624
Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E. 61
29916747 2018
625
Siamese Crocodile White Blood Cell Extract Inhibits Cell Proliferation and Promotes Autophagy in Multiple Cancer Cell Lines. 61
29847866 2018
626
CO suppresses prostate cancer cell growth by directly targeting LKB1/AMPK/mTOR pathway in vitro and in vivo. 61
29566977 2018
627
Two new Cu(II) dipeptide complexes based on 5-methyl-2-(2'-pyridyl)benzimidazole as potential antimicrobial and anticancer drugs: Special exploration of their possible anticancer mechanism. 61
29803995 2018
628
(-)-Shikimic Acid as a Chiral Building Block for the Synthesis of New Cytotoxic 6-Aza-Analogues of Angucyclinones. 61
29895756 2018
629
Cytotoxic Drimane Sesquiterpenoids Isolated from Perenniporia maackiae. 61
29878761 2018
630
7-Farnesyloxycoumarin Exerts Anti-cancer Effects on a Prostate Cancer Cell Line by 15-LOX-1 Inhibition. 61
29940744 2018
631
Design, synthesis, antiproliferative activity and docking studies of quinazoline derivatives bearing 2,3-dihydro-indole or 1,2,3,4-tetrahydroquinoline as potential EGFR inhibitors. 61
29775935 2018
632
α-Viniferin activates autophagic apoptosis and cell death by reducing glucocorticoid receptor expression in castration-resistant prostate cancer cells. 61
29904891 2018
633
Chalcomoracin is a potent anticancer agent acting through triggering Oxidative stress via a mitophagy- and paraptosis-dependent mechanism. 61
29934599 2018
634
A novel Tc-99m and fluorescence-labeled arginine-arginine-leucine-containing peptide as a multimodal tumor imaging agent in a murine tumor model. 61
29603784 2018
635
Design, synthesis, and antitumor evaluation of quinoline-imidazole derivatives. 61
29732607 2018
636
Long noncoding RNA BDNF-AS is associated with clinical outcomes and has functional role in human prostate cancer. 61
29710528 2018
637
Biological evaluation of water soluble arene Ru(II) enantiomers with amino-oxime ligands. 61
29529470 2018
638
Polyprenylated polycyclic acylphloroglucinol: Angiogenesis inhibitor from Garcinia multiflora. 61
29655982 2018
639
Design, Synthesis and Biological Evaluation of Novel Phenylsulfonylurea Derivatives as PI3K/mTOR Dual Inhibitors. 61
29954109 2018
640
Luteolin attenuates Wnt signaling via upregulation of FZD6 to suppress prostate cancer stemness revealed by comparative proteomics. 61
29867083 2018
641
Cytotoxic Activity and Structure-Activity Relationship of Triazole-Containing Bis(Aryl Ether) Macrocycles. 61
29771004 2018
642
Synthesis and biological evaluation of estrone 3-O-ether derivatives containing the piperazine moiety. 61
29476759 2018
643
Chiral resolution and anticancer effect of xanthones from Garcinia paucinervis. 61
29474978 2018
644
Preclinical Development of Novel PSMA-Targeting Radioligands: Modulation of Albumin-Binding Properties To Improve Prostate Cancer Therapy. 61
29684274 2018
645
Hapalindole H Induces Apoptosis as an Inhibitor of NF-ĸB and Affects the Intrinsic Mitochondrial Pathway in PC-3 Androgen-insensitive Prostate Cancer Cells. 61
29848677 2018
646
MicroRNA-206 regulates the epithelial-mesenchymal transition and inhibits the invasion and metastasis of prostate cancer cells by targeting Annexin A2. 61
29805562 2018
647
Evaluation of A-ring fused pyridine d-modified androstane derivatives for antiproliferative and aldo-keto reductase 1C3 inhibitory activity. 61
30108986 2018
648
Extraction, profiling and bioactivity analysis of volatile glucosinolates present in oil extract of Brassica juncea var. raya. 61
29692548 2018
649
Long non-coding RNA CCAT1 promotes the migration and invasion of prostate cancer PC-3 cells. 61
29863242 2018
650
Subcellular localization of aquaporin 3 in prostate cancer is regulated by RalA. 61
29532894 2018
651
Synthesis, biological evaluation and molecular docking study of 1-amino-2-aroylnaphthalenes against prostate cancer. 61
29606573 2018
652
MiR-206 inhibits proliferation and migration of prostate cancer cells by targeting CXCL11. 61
29542173 2018
653
Novel 64Cu Labeled RGD2-BBN Heterotrimers for PET Imaging of Prostate Cancer. 61
29587479 2018
654
Prostate Cancer Cell-Specific Cytotoxicity of Sub-Micron Potassium Niobate Powder. 61
29442813 2018
655
A new metabolic gene signature in prostate cancer regulated by JMJD3 and EZH2. 61
29805743 2018
656
[Retracted] Apogossypolone inhibits the proliferation of LNCaP cells in vitro and in vivo. 61
29436677 2018
657
Sulfamic acid promoted one-pot synthesis of phenanthrene fused-dihydrodibenzo-quinolinones: Anticancer activity, tubulin polymerization inhibition and apoptosis inducing studies. 61
29525336 2018
658
Loss of scinderin decreased expression of epidermal growth factor receptor and promoted apoptosis of castration-resistant prostate cancer cells. 61
29744289 2018
659
Synthesis, biological evaluation and SAR of naftopidil-based arylpiperazine derivatives. 61
29615343 2018
660
Microwave-assisted one-pot synthesis of new phenanthrene fused-tetrahydrodibenzo-acridinones as potential cytotoxic and apoptosis inducing agents. 61
29609122 2018
661
Camel milk attenuates methotrexate-induced kidney injury via activation of PI3K/Akt/eNOS signaling and intervention with oxidative aberrations. 61
29667662 2018
662
Femoral rotational asymmetry is a common anatomical variant. 61
29359478 2018
663
Regulatory effects of antitumor agent matrine on FOXO and PI3K-AKT pathway in castration-resistant prostate cancer cells. 61
29119376 2018
664
Chemokine CXCL3 mediates prostate cancer cells proliferation, migration and gene expression changes in an autocrine/paracrine fashion. 61
29524043 2018
665
A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo. 61
29669200 2018
666
Structure-activity relationships of succinimidyl-Cys-C(O)-Glu derivatives with different near-infrared fluorophores as optical imaging probes for prostate-specific membrane antigen. 61
29580851 2018
667
Ajmaline, Oxindole, and Cytotoxic Macroline-Akuammiline Bisindole Alkaloids from Alstonia penangiana. 61
29746134 2018
668
Theranostic Pt(IV) Conjugate with Target Selectivity for Androgen Receptor. 61
29667815 2018
669
Discovery of 6-chloro-2-(propylthio)-8,9-dihydro-7H-purines containing a carboxamide moiety as potential selective anti-lung cancer agents. 61
29635165 2018
670
Efficacy Against Human Prostate Cancer by Prostate-specific Membrane Antigen-specific, Transforming Growth Factor-β Insensitive Genetically Targeted CD8+ T-cells Derived from Patients with Metastatic Castrate-resistant Disease. 61
29275833 2018
671
Radiometal-Dependent Biological Profile of the Radiolabeled Gastrin-Releasing Peptide Receptor Antagonist SB3 in Cancer Theranostics: Metabolic and Biodistribution Patterns Defined by Neprilysin. 61
29664606 2018
672
Water soluble glucose derivative of thiocarbohydrazone acts as ionophore with cytotoxic effects on tumor cells. 61
29452884 2018
673
Transition from androgenic to neurosteroidal action of 5α-androstane-3α, 17β-diol through the type A γ-aminobutyric acid receptor in prostate cancer progression. 61
29155210 2018
674
MiR-1271 Inhibits Cell Growth in Prostate Cancer by Targeting ERG. 61
28551819 2018
675
Combinatorial strategy of epigenetic and hormonal therapies: A novel promising approach for treating advanced prostate cancer. 61
29455003 2018
676
GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling. 61
29431615 2018
677
Prazosin but Not Tamsulosin Sensitises PC-3 and LNCaP Prostate Cancer Cells to Docetaxel. 61
29669348 2018
678
p62 as a therapeutic target for inhibition of autophagy in prostate cancer. 61
29368435 2018
679
Crosstalk Between Androgen-sensitive and Androgen-insensitive Prostate Cancer Cells. 61
29599322 2018
680
Selective Androgen Receptor Modulator S42 Suppresses Prostate Cancer Cell Proliferation. 61
29444261 2018
681
Integrin αVβ3-targeted SPECT/CT for the assessment of Bevacizumab therapy in orthotopic lung cancer xenografts. 61
29541186 2018
682
JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice. 61
29248440 2018
683
Multiple protective effect of peptides released from Olea europaea and Prunus persica seeds against oxidative damage and cancer cell proliferation. 61
29579948 2018
684
A Bowman-Birk type chymotrypsin inhibitor peptide from the amphibian, Hylarana erythraea. 61
29643444 2018
685
Synthesis, Radiolabelling and In Vitro Imaging of Multifunctional Nanoceramics. 61
29938196 2018
686
Novel hybrids of brefeldin A and nitrogen mustards with improved antiproliferative selectivity: Design, synthesis and antitumor biological evaluation. 61
29524728 2018
687
Design, synthesis and anticancer studies of novel aminobenzazolyl pyrimidines as tyrosine kinase inhibitors. 61
29342447 2018
688
LTBP3 promotes early metastatic events during cancer cell dissemination. 61
29348457 2018
689
Electrical Impedance Measurements of Biological Cells in Response to External Stimuli. 61
29402081 2018
690
Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells. 61
29653561 2018
691
Cytotoxic protobassic acid saponins from the kernels of Palaquium formosanum. 61
29567224 2018
692
New Gastrin Releasing Peptide Receptor-Directed [99mTc]Demobesin 1 Mimics: Synthesis and Comparative Evaluation. 61
29517903 2018
693
Bioactive Indolocarbazoles from the Marine-Derived Streptomyces sp. DT-A61. 61
29558119 2018
694
Three new elemanolides from the seeds of Vernonia anthelmintica. 61
28675942 2018
695
A novel Salvialactomine from the callus culture of Salvia santolinifolia Boiss. 61
28412869 2018
696
MiRNALet-7a mediates prostate cancer PC-3 cell invasion, migration by inducing epithelial-mesenchymal transition through CCR7/MAPK pathway. 61
29236328 2018
697
Effect of quercetin glucosides from Allium extracts on HepG2, PC-3 and HT-29 cancer cell lines. 61
29552109 2018
698
MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway. 61
29353209 2018
699
Phosphoglycerate mutase 1 knockdown inhibits prostate cancer cell growth, migration, and invasion. 61
29271400 2018
700
Testosterone metabolites inhibit proliferation of castration- and therapy-resistant prostate cancer. 61
29682196 2018
701
Upregulation of miR-191 promotes cell growth and invasion via targeting TIMP3 in prostate cancer. 61
29745091 2018
702
NAC1 promotes the migration of prostate cancer cells and participates in osteoclastogenesis by negatively regulating IFNβ. 61
29435019 2018
703
Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines. 61
29662635 2018
704
[Over-expression of miR-151a-3p inhibits proliferation and migration of PC-3 prostate cancer cells]. 61
29773107 2018
705
Capillarisin blocks prostate-specific antigen expression on activation of androgen receptor in prostate carcinoma cells. 61
29164633 2018
706
Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4. 61
29269867 2018
707
The 5T4 oncofetal glycoprotein does not act as a general organizer of the CXCL12 system in cancer cells. 61
29408206 2018
708
Identification of N-arylsulfonylpyrimidones as anticancer agents. 61
29332183 2018
709
Synthesis and Antiproliferative Activity of Minor Hops Prenylflavonoids and New Insights on Prenyl Group Cyclization. 61
29597299 2018
710
Green Synthesis of Carbon Dots Derived from Walnut Oil and an Investigation of Their Cytotoxic and Apoptogenic Activities toward Cancer Cells. 61
29670850 2018
711
Androgen receptor (AR) degradation enhancer ASC-J9® in an FDA-approved formulated solution suppresses castration resistant prostate cancer cell growth. 61
29203251 2018
712
Synthesis and properties of N-methylimidazole solvates of vanadium(ii), chromium(ii) and iron(ii) phthalocyanines. Strong NIR absorption in VII(MeIm)2(Pc2-). 61
29528080 2018
713
Curcumin inspired 2-chloro/phenoxy quinoline analogues: Synthesis and biological evaluation as potential anticancer agents. 61
29429834 2018
714
Albumin-Binding PSMA Ligands: Optimization of the Tissue Distribution Profile. 61
29400475 2018
715
Monomeric and Dimeric 68Ga-Labeled Bombesin Analogues for Positron Emission Tomography (PET) Imaging of Tumors Expressing Gastrin-Releasing Peptide Receptors (GRPrs). 61
29432691 2018
716
Activation of estrogen receptor beta (ERβ) regulates the expression of N-cadherin, E-cadherin and β-catenin in androgen-independent prostate cancer cells. 61
29341930 2018
717
Engineering of the Trichoderma reesei xylanase3 promoter for efficient enzyme expression. 61
29417196 2018
718
Identification of a novel 2-oxindole fluorinated derivative as in vivo antitumor agent for prostate cancer acting via AMPK activation. 61
29531259 2018
719
Bacillus amyloliquefaciens induces production of a novel blennolide K in coculture of Setophoma terrestris. 61
29288594 2018
720
Transcription factor FoxM1 is the downstream target of c-Myc and contributes to the development of prostate cancer. 61
29554906 2018
721
Synthesis and cytotoxic effect of pregnenolone derivatives with one or two α,β-unsaturated carbonyls and an ester moiety at C-21 or C-3. 61
29360536 2018
722
Prostaglandin E2 receptor EP4 is involved in the cell growth and invasion of prostate cancer via the cAMP‑PKA/PI3K‑Akt signaling pathway. 61
29328471 2018
723
Class I HDAC Inhibitors Display Different Antitumor Mechanism in Leukemia and Prostatic Cancer Cells Depending on Their p53 Status. 61
29499113 2018
724
Simvastatin in combination with meclofenamic acid inhibits the proliferation and migration of human prostate cancer PC-3 cells via an AKR1C3 mechanism. 61
29435052 2018
725
Maspin Enhances the Anticancer Activity of Curcumin in Hormone-refractory Prostate Cancer Cells. 61
29374713 2018
726
Quercetin reverses the doxorubicin resistance of prostate cancer cells by downregulating the expression of c-met. 61
29434932 2018
727
Synthesis and biological evaluation of new steroidal pyridines as potential anti-prostate cancer agents. 61
29310026 2018
728
Oxibendazole inhibits prostate cancer cell growth. 61
29434928 2018
729
Novel enmein-type diterpenoid hybrids coupled with nitrogen mustards: Synthesis of promising candidates for anticancer therapeutics. 61
29407983 2018
730
Synthesis of gold(I) phosphine complexes containing the 2-BrC6F4PPh2 ligand: Evaluation of anticancer activity in 2D and 3D spheroidal models of HeLa cancer cells. 61
29331752 2018
731
Efficacy of the highly selective focal adhesion kinase inhibitor BI 853520 in adenocarcinoma xenograft models is linked to a mesenchymal tumor phenotype. 61
29472531 2018
732
Synthesis and biological evaluation of novel bavachinin analogs as anticancer agents. 61
29335212 2018
733
Ultrasensitive electrochemical immunosensing of tumor suppressor protein p53 in unprocessed human plasma and cell lysates using a novel nanocomposite based on poly-cysteine/graphene quantum dots/gold nanoparticle. 61
29113888 2018
734
Sarcosine influences apoptosis and growth of prostate cells via cell-type specific regulation of distinct sets of genes. 61
29105933 2018
735
Dietary Glycation Products Regulate Immune Homeostasis: Early Glycation Products Promote Prostate Cancer Cell Proliferation through Modulating Macrophages. 61
29082675 2018
736
Design, synthesis and evaluation of novel N-hydroxybenzamides/N-hydroxypropenamides incorporating quinazolin-4(3H)-ones as histone deacetylase inhibitors and antitumor agents. 61
29223029 2018
737
Dual targeting c-met and VEGFR2 in osteoblasts suppresses growth and osteolysis of prostate cancer bone metastasis. 61
29174801 2018
738
Development and formulation of Moringa oleifera standardised leaf extract film dressing for wound healing application. 61
29080829 2018
739
Synthesis, optical properties and cytotoxicity of meso-heteroatom substituted IR-786 analogs. 61
29249562 2018
740
Antineoplastic activity of isoliquiritigenin, a chalcone compound, in androgen-independent human prostate cancer cells linked to G2/M cell cycle arrest and cell apoptosis. 61
29277717 2018
741
Synthesis and bioevaluation and doking study of 1H-pyrrolo[2,3-b]pyridine derivatives bearing aromatic hydrazone moiety as c-Met inhibitors. 61
29331754 2018
742
Design, synthesis and in vitro biological evaluation of novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing a thiosemicarbazide moiety. 61
29407946 2018
743
Structurally Diverse Cytotoxic Dimeric Chalcones from Oxytropis chiliophylla. 61
29400468 2018
744
Heterocyclic-Fused Pyrimidines as Novel Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site: Structural Basis and Antitumor Efficacy. 61
29406710 2018
745
Positron Emission Tomography Imaging of Prostate Cancer with Ga-68-Labeled Gastrin-Releasing Peptide Receptor Agonist BBN7-14 and Antagonist RM26. 61
29254329 2018
746
Discovery of novel jaspine B analogues as autophagy inducer. 61
29254641 2018
747
Annonalide and derivatives: Semisynthesis, cytotoxic activities and studies on interaction of annonalide with DNA. 61
29413989 2018
748
Long non-coding RNA NAP1L6 promotes tumor progression and predicts poor prognosis in prostate cancer by targeting Inhibin-β A. 61
30154665 2018
749
Phytochemical Study and Evaluation of the Cytotoxic Properties of Methanolic Extract from Baccharis obtusifolia. 61
30155301 2018
750
THE IMPACT OF ALCOHOL ON PRO-METASTATIC N-GLYCOSYLATION IN PROSTATE CANCER. 61
31131224 2018
751
Potential anticancer activity of biogenic silver nanoparticles using leaf extract of Rhynchosia suaveolens: an insight into the mechanism. 61
29301413 2018
752
Minimally Invasive Fibrin Sealant Application in Pilonidal Sinus: A Comparative Study. 61
30414361 2018
753
MicroRNA-144-3p inhibits cell proliferation and induces cell apoptosis in prostate cancer by targeting CEP55. 61
30210684 2018
754
Effect of prostate cancer cell line supernatant on functional polarization in macrophages. 61
30160162 2018
755
Detection of exosome miRNAs using molecular beacons for diagnosing prostate cancer. 61
30033809 2018
756
MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis. 61
30282072 2018
757
Hybrid nanocarrier system for guiding and augmenting simvastatin cytotoxic activity against prostate cancer. 61
30295086 2018
758
AZD5153 Inhibits Prostate Cancer Cell Growth in Vitro and in Vivo. 61
30308485 2018
759
Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles. 61
29391790 2018
760
Model-driven discovery of long-chain fatty acid metabolic reprogramming in heterogeneous prostate cancer cells. 61
29293497 2018
761
Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells. 61
29098395 2018
762
Targeting DNA repair with PNKP inhibition sensitizes radioresistant prostate cancer cells to high LET radiation. 61
29320576 2018
763
microRNA-323 upregulation promotes prostate cancer growth and docetaxel resistance by repressing p73. 61
29091904 2018
764
Fenofibrate inhibits mTOR-p70S6K signaling and simultaneously induces cell death in human prostate cancer cells. 61
29305864 2018
765
Plumbagin Triggers ER Stress-Mediated Apoptosis in Prostate Cancer Cells via Induction of ROS. 61
29357323 2018
766
α-Pinene Inhibits Human Prostate Cancer Growth in a Mouse Xenograft Model. 61
29069647 2018
767
CRMP4a suppresses cell motility by sequestering RhoA activity in prostate cancer cells. 61
30081723 2018
768
Chelerythrine induced cell death through ROS-dependent ER stress in human prostate cancer cells. 61
29780252 2018
769
miR-29b enhances prostate cancer cell invasion independently of MMP-2 expression. 61
29440967 2018
770
Dihydroisotanshinone I combined with radiation inhibits the migration ability of prostate cancer cells through DNA damage and CCL2 pathway. 61
29386061 2018
771
Low-dose irradiation inhibits proliferation of the p53null type human prostate cancer cells through the ATM/p21 pathway. 61
29115439 2018
772
Bovine Milk Lactoferrin Selectively Kills Highly Metastatic Prostate Cancer PC-3 and Osteosarcoma MG-63 Cells In Vitro. 61
29915723 2018
773
Silencing of vacuolar ATPase c subunit ATP6V0C inhibits the invasion of prostate cancer cells through a LASS2/TMSG1-independent manner. 61
29138865 2018
774
Comparison of [17(20)E]-21-Norpregnene oxazolinyl and benzoxazolyl derivatives as inhibitors of CYP17A1 activity and prostate carcinoma cells growth. 61
29183745 2018
775
Isobavachalcone Induces ROS-Mediated Apoptosis via Targeting Thioredoxin Reductase 1 in Human Prostate Cancer PC-3 Cells. 61
30410640 2018
776
Design, synthesis and preliminary biological evaluation of 5,8-dihydropteridine-6,7-diones that induce apoptosis and suppress cell migration. 61
29133051 2018
777
Novel solid-phase strategy for the synthesis of ligand-targeted fluorescent-labelled chelating peptide conjugates as a theranostic tool for cancer. 61
30410628 2018
778
Discovery of novel quinazoline derivatives bearing semicarbazone moiety as potent EGFR kinase inhibitors. 61
30455856 2018
779
STAT3-Mediated Transcriptional Regulation of Osteopontin in STAT3 Loss-of-Function Related Hyper IgE Syndrome. 61
29868029 2018
780
Induction of Different Apoptosis Pathways by Two Proteusmirabilis Clinical Isolates Strains in Prostatic Epithelial Cells. 61
30618851 2018
781
Etoposide encased folic acid adorned mesoporous silica nanoparticles as potent nanovehicles for enhanced prostate cancer therapy: synthesis, characterization, cellular uptake and biodistribution. 61
30669865 2018
782
pH-triggered charge-reversal and redox-sensitive drug-release polymer micelles codeliver doxorubicin and triptolide for prostate tumor therapy. 61
30510415 2018
783
N-Glycosylation of Lipocalin 2 Is Not Required for Secretion or Exosome Targeting. 61
29755357 2018
784
A cytotoxic flavonol glycoside from Melaleuca leucadendra leaves extract with immunostimulant activity. 61
29441953 2018
785
Parallel Solid-Phase Synthesis using a New Diethylsilylacetylenic Linker and Leading to Mestranol Derivatives with Potent Antiproliferative Activities on Multiple Cancer Cell Lines. 61
29521249 2018
786
CNOT2 promotes proliferation and angiogenesis via VEGF signaling in MDA-MB-231 breast cancer cells. 61
29024811 2018
787
Glutathione salts of O,O-diorganyl dithiophosphoric acids: Synthesis and study as redox modulating and antiproliferative compounds. 61
28993278 2018
788
4-aryl/heteroaryl-4H-fused Pyrans as Anti-proliferative Agents: Design, Synthesis and Biological Evaluation. 61
28925877 2018
789
A Potent, Metabolically Stable Tubulin Inhibitor Targets the Colchicine Binding Site and Overcomes Taxane Resistance. 61
29180476 2018
790
Camel Milk Ameliorates 5-Fluorouracil-Induced Renal Injury in Rats: Targeting MAPKs, NF-κB and PI3K/Akt/eNOS Pathways. 61
29694984 2018
791
Prodrugs for Nitroreductase Based Cancer Therapy- 1: Metabolite Profile, Cell Cytotoxicity and Molecular Modeling Interactions of Nitro Benzamides with Ssap-NtrB. 61
29189173 2018
792
Development and in-vitro characterization of nanoemulsions loaded with paclitaxel/γ-tocotrienol lipid conjugates. 61
29195915 2018
793
Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironment. 61
29415026 2018
794
IDK1 is a rat monoclonal antibody against hypoglycosylated bone sialoprotein with application as biomarker and therapeutic agent in breast cancer skeletal metastasis. 61
29416877 2018
795
Pomegranate extract-loaded solid lipid nanoparticles: design, optimization, and in vitro cytotoxicity study. 61
29563789 2018
796
[Overexpression of miR-519d-3p inhibits the proliferation of DU-145 prostate cancer cells by reducing TRAF4]. 61
29595452 2018
797
Dose Escalation of Vitamin D3 Yields Similar Cryosurgical Outcome to Single Dose Exposure in a Prostate Cancer Model. 61
29480024 2018
798
Novel Hydroxamic Acids Incorporating 1-((1H-1,2,3-Triazol-4-yl)methyl)- 3-substituted-2-oxoindolines: Synthesis, Biological Evaluation and SAR Analysis. 61
29807520 2018
799
Clofoctol and sorafenib inhibit prostate cancer growth via synergistic induction of endoplasmic reticulum stress and UPR pathways. 61
30425575 2018
800
Synthesis and biological evaluation of curcumin inspired imidazo[1,2-a]pyridine analogues as tubulin polymerization inhibitors. 61
29174816 2018
801
Design, Synthesis and Cytotoxicity Evaluation of New 3, 5-Disubstituted-2-Thioxoimidazolidinones. 61
29189182 2018
802
Dietary flavonoid tangeretin induces reprogramming of epithelial to mesenchymal transition in prostate cancer cells by targeting the PI3K/Akt/mTOR signaling pathway. 61
29375715 2018
803
Anethole Inhibits the Proliferation of Human Prostate Cancer Cells via Induction of Cell Cycle Arrest and Apoptosis. 61
28745237 2018
804
Synthesis and evaluation of novel thiazole-based derivatives as selective inhibitors of DNA-binding domain of the androgen receptor. 61
28667662 2018
805
Bombesin/oligoarginine fusion peptides for gastrin releasing peptide receptor (GRPR) targeted gene delivery. 61
29269254 2018
806
Comparative Assay of 2D and 3D Cell Culture Models: Proliferation, Gene Expression and Anticancer Drug Response. 61
29623827 2018
807
Synthesis and biological evaluation of novel 2-arylvinyl-substituted naphtho[2,3-d]imidazolium halide derivatives as potent antitumor agents. 61
29288947 2018
808
Synthesis and Characterization of the Hemi-Salen Ligands and Their Triboron Complexes: Spectroscopy and Examination of Anticancer Properties. 61
29032600 2018
809
Design, synthesis and cytotoxic activity of N-Modified oleanolic saponins bearing A glucosamine. 61
29133061 2018
810
Cyclodipeptide c(Orn-Pro) Conjugate with 4-Ethylpiperic Acid Abrogates Cancer Cell Metastasis through Modulating MDM2. 61
29216716 2018
811
Cytotoxic quinazoline alkaloids from the seeds of Peganum harmala. 61
29229205 2018
812
Design, Synthesis and Evaluation of Substituted Aryl-2-Nitrovinyl Derivatives as Small Molecules Proteasome Inhibitors. 61
30127814 2018
813
Synthesis and Biological Evaluation of Novel Triazoles Linked 7-hydroxycoumarin as Potent Cytotoxic Agents. 61
29298653 2018
814
Gene therapy with RALA/iNOS composite nanoparticles significantly enhances survival in a model of metastatic prostate cancer. 61
29899810 2018
815
In Vitro Evaluation of Cytotoxic Activities of Marketed Herbal Products in Ghana. 61
30088418 2018
816
CCAAT enhancer binding protein β promotes tumor growth and inhibits apoptosis in prostate cancer by methylating estrogen receptor β. 61
29322786 2018
817
Para-Toluenesulfonamide Induces Anti-tumor Activity Through Akt-Dependent and -Independent mTOR/p70S6K Pathway: Roles of Lipid Raft and Cholesterol Contents. 61
30555320 2018
818
Bio-Guided Fractionation of Papaya Leaf Juice for Delineating the Components Responsible for the Selective Anti-proliferative Effects on Prostate Cancer Cells. 61
30505274 2018
819
Preparation of 68Ga-PSMA-11 with a Synthesis Module for Micro PET-CT Imaging of PSMA Expression during Prostate Cancer Progression. 61
29853810 2018
820
Exploration of Novel 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia by 2D/3D QSAR, Cytotoxicity Pre-ADME and Docking Studies. 61
30659542 2018
821
Inhibition of EZH2 and EGFR produces a synergistic effect on cell apoptosis by increasing autophagy in gastric cancer cells. 61
30555238 2018
822
Diversity Modification and Structure-Activity Relationships of Two Natural Products 1β-hydroxy Alantolactone and Ivangustin as Potent Cytotoxic Agents. 61
29379131 2018
823
Iridoids and sfingolipids from Hedyotis diffusa. 61
29122633 2018
824
Reaction of tin(iv) phthalocyanine dichloride with decamethylmetallocenes (M = CrII and CoII). Strong magnetic coupling of spins in (Cp*2Co+){SnIVCl2(Pc˙3-)}˙-·2C6H4Cl2. 61
29299581 2018
825
Hemolytic, anticancer and antigiardial activity of Palythoa caribaeorum venom. 61
29692802 2018
826
A Novel Dual HDAC6 and Tubulin Inhibitor, MPT0B451, Displays Anti-tumor Ability in Human Cancer Cells in Vitro and in Vivo. 61
29593536 2018
827
Inhibition of human prostate cancer (PC-3) cells and targeting of PC-3-derived prostate cancer stem cells with koenimbin, a natural dietary compound from Murraya koenigii (L) Spreng. 61
29765202 2018
828
MicroRNA 200c-3p regulates autophagy via upregulation of endoplasmic reticulum stress in PC-3 cells. 61
29308051 2018
829
Antiproliferative Activity and VEGF Expression Reduction in MCF7 and PC-3 Cancer Cells by Paclitaxel and Imatinib Co-encapsulation in Folate-Targeted Liposomes. 61
28681330 2018
830
Low-frequency ultrasound enhances chemotherapy sensitivity and induces autophagy in PTX-resistant PC-3 cells via the endoplasmic reticulum stress-mediated PI3K/Akt/mTOR signaling pathway. 61
30254455 2018
831
High Glucose Induces VEGF-C Expression via the LPA1/3-Akt-ROS-LEDGF Signaling Axis in Human Prostate Cancer PC-3 Cells. 61
30317243 2018
832
Effects of pheophorbide a-mediated photodynamic therapy on proliferation and metastasis of human prostate cancer cells. 61
29271988 2017
833
Dental pulp stem cells (DPSCs) increase prostate cancer cell proliferation and migration under in vitro conditions. 61
29054337 2017
834
Chrysin induces death of prostate cancer cells by inducing ROS and ER stress. 61
28213961 2017
835
siRNA-Mediated Silencing of CIP2A Enhances Docetaxel Activity Against PC-3 Prostate Cancer Cells. 61
29399554 2017
836
The novel role of IL-37 in prostate cancer: evidence as a promising radiosensitizer. 61
29210005 2017
837
[Silencing of vacuolar ATPase c subunit ATP6V0C inhibits invasion of prostate cancer cells]. 61
29263462 2017
838
Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer. 61
29202848 2017
839
Bioactivity-guided isolation of anti-proliferative compounds from endemic Centaurea kilaea. 61
27938087 2017
840
Synthesis, characterization and evaluation cytotoxic activity of silver nanoparticles synthesized by Chinese herbal Cornus officinalis via environment friendly approach. 61
28886426 2017
841
Insulin-like growth factor-I induces chemoresistence to docetaxel by inhibiting miR-143 in human prostate cancer. 61
29291019 2017
842
Efficiency of novel nanocombinations of bovine milk proteins (lactoperoxidase and lactoferrin) for combating different human cancer cell lines. 61
29196676 2017
843
miR-20b promotes cellular proliferation and migration by directly regulating phosphatase and tensin homolog in prostate cancer. 61
29163708 2017
844
The Sam-Sam interaction between Ship2 and the EphA2 receptor: design and analysis of peptide inhibitors. 61
29234063 2017
845
Preparation, characterization and cytotoxic evaluation of bovine serum albumin nanoparticles encapsulating 5-methylmellein: A secondary metabolite isolated from Xylaria psidii. 61
29100800 2017
846
Pharmacological evaluation of 2-angeloyl ent-dihydrotucumanoic acid. 61
28142303 2017
847
An innovative immunosensor for detection of tumor suppressor protein p53 in unprocessed human plasma and cancer cell lysates. 61
28774804 2017
848
Antiproliferative activity of spinasterol isolated of Stegnosperma halimifolium (Benth, 1844). 61
30166901 2017
849
MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer. 61
29035829 2017
850
Passive air sampling of polybrominated diphenyl ethers in New Delhi, Kolkata, Mumbai and Chennai: Levels, homologous profiling and source apportionment. 61
28911793 2017
851
Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer. 61
29206996 2017
852
Investigation of c-KIT and Ki67 expression in normal, preneoplastic and neoplastic canine prostate. 61
29207991 2017
853
Baicalein suppresses the androgen receptor (AR)-mediated prostate cancer progression via inhibiting the AR N-C dimerization and AR-coactivators interaction. 61
29285272 2017
854
Cytotoxic, antioxidative, genotoxic and antigenotoxic effects of Horchata, beverage of South Ecuador. 61
29258490 2017
855
Multi-scale mechanical characterization of prostate cancer cell lines: Relevant biological markers to evaluate the cell metastatic potential. 61
28899829 2017
856
The Combination of Metformin and Valproic Acid Induces Synergistic Apoptosis in the Presence of p53 and Androgen Signaling in Prostate Cancer. 61
28802253 2017
857
Histone Deacetylase (HDAC) Inhibitor, Suberoylanilide Hydroxamic Acid (SAHA), Induces Apoptosis in Prostate Cancer Cell Lines via the Akt/FOXO3a Signaling Pathway. 61
29211704 2017
858
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617-preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617. 61
28102507 2017
859
Photodynamic therapy using a cytotoxic photosensitizer porphyrus envelope that targets the cell membrane. 61
29079353 2017
860
Discovery of novel pyrrolo-pyridine/pyrimidine derivatives bearing pyridazinone moiety as c-Met kinase inhibitors. 61
29107421 2017
861
Synthesis and Evaluation of Radiolabeled Phosphoramide Mustard with Selectivity for Hypoxic Cancer Cells. 61
29259746 2017
862
High-speed broadband monitoring of cell viscoelasticity in real time shows myosin-dependent oscillations. 61
28597224 2017
863
NADPH oxidase 5 (NOX5)-induced reactive oxygen signaling modulates normoxic HIF-1α and p27Kip1 expression in malignant melanoma and other human tumors. 61
28762556 2017
864
Bibenzyl-Based Meroterpenoid Enantiomers from the Chinese Liverwort Radula sumatrana. 61
29215886 2017
865
Identification of CpG Sites of SERPINA5 Promoter with Opposite Methylation Patterns in Benign and Malignant Prostate Cells. 61
29187436 2017
866
In vitro growth inhibition and cytotoxicity of Euphorbia caducifolia against four human cancer cell lines and its phytochemical characterisation. 61
28403658 2017
867
Oleanolic acid methyl ester, a novel cytotoxic mitocan, induces cell cycle arrest and ROS-Mediated cell death in castration-resistant prostate cancer PC-3 cells. 61
29031200 2017
868
Corrigendum to "The suppression of torulene and torularhodin treatment on the growth of PC-3 xenograft prostate tumors" [Biochem. Biophys. Res. Communi. (469/4) (2016) 1146-1152]. 61
29102030 2017
869
Regulated expression of the TPβ isoform of the human T prostanoid receptor by the tumour suppressors FOXP1 and NKX3.1: Implications for the role of thromboxane in prostate cancer. 61
28890397 2017
870
Individual serum saturated fatty acids and markers of chronic subclinical inflammation: the Insulin Resistance Atherosclerosis Study. 61
28928169 2017
871
F-actin reorganization by V-ATPase inhibition in prostate cancer. 61
29038303 2017
872
[Role of adiponectin in prostate cancer: A preliminary study]. 61
29738161 2017
873
miR-564 inhibited metastasis and proliferation of prostate cancer by targeting MLLT3. 61
29164580 2017
874
A standardized herbal extract mitigates tumor inflammation and augments chemotherapy effect of docetaxel in prostate cancer. 61
29142311 2017
875
High expression of PDLIM5 facilitates cell tumorigenesis and migration by maintaining AMPK activation in prostate cancer. 61
29228678 2017
876
miR-483-5p promotes prostate cancer cell proliferation and invasion by targeting RBM5. 61
28727371 2017
877
Discovery of peptide drug carrier candidates for targeted multi-drug delivery into prostate cancer cells. 61
28888997 2017
878
[Effect of silencing the VDR gene on the migration and invasion of prostate cancer cells]. 61
29738160 2017
879
Targeting protein geranylgeranylation slows tumor development in a murine model of prostate cancer metastasis. 61
27624889 2017
880
Synthesis, characterization and molecular docking studies of thiouracil derivatives as potent thymidylate synthase inhibitors and potential anticancer agents. 61
28815411 2017
881
Attomolar detection of extracellular microRNAs released from living prostate cancer cells by a plasmonic nanowire interstice sensor. 61
29095457 2017
882
The Antitumor Constituents from Hedyotis Diffusa Willd. 61
29189741 2017
883
Alkyne-azide cycloaddition analogues of dehydrozingerone as potential anti-prostate cancer inhibitors via the PI3K/Akt/NF-kB pathway. 61
30108729 2017
884
Synthesis and Assessment of Peptide Gd-DOTA Conjugates Targeting Extradomain B Fibronectin for Magnetic Resonance Molecular Imaging of Prostate Cancer. 61
28976766 2017
885
Short hybrid peptides incorporating β- and γ-amino acids as antimicrobial agents. 61
28962891 2017
886
Design and synthesis of novel nitrogen mustard-evodiamine hybrids with selective antiproliferative activity. 61
29037951 2017
887
Cytotoxic effect of Cyperus rotundus rhizome extract on human cancer cell lines. 61
28946185 2017
888
Synthesis and Biological Evaluation of Ru(II) and Pt(II) Complexes Bearing Carboxyl Groups as Potential Anticancer Targeted Drugs. 61
29099179 2017
889
Enantiomerically pure β-dipeptide derivative induces anticancer activity against human hormone-refractory prostate cancer through both PI3K/Akt-dependent and -independent pathways. 61
29228561 2017
890
Targeting Phosphatidylinositol 3-Kinase Signaling Pathway for Therapeutic Enhancement of Vascular-Targeted Photodynamic Therapy. 61
28835385 2017
891
Kisspeptin inhibits cancer growth and metastasis via activation of EIF2AK2. 61
28944853 2017
892
Hydrogen peroxide production is affected by oxygen levels in mammalian cell culture. 61
28899780 2017
893
Induction of alpha-methylacyl-CoA racemase by miR-138 via up-regulation of β-catenin in prostate cancer cells. 61
28741117 2017
894
Two novel peptides derived from Sinonovacula constricta inhibit the proliferation and induce apoptosis of human prostate cancer cells. 61
28901516 2017
895
Synthesis and biological evaluation of glycosides containing triazene-chalcones. 61
28791568 2017
896
Molecular diversity of phenothiazines: design and synthesis of phenothiazine-dithiocarbamate hybrids as potential cell cycle blockers. 61
28785928 2017
897
Synthesis and evaluation of a novel near-infrared fluorescent probe based on succinimidyl-Cys-C(O)-Glu that targets prostate-specific membrane antigen for optical imaging. 61
28964633 2017
898
Design, synthesis, and evaluation of novel Akt1 inhibitors based on an indole scaffold. 61
28390089 2017
899
DMAPT inhibits NF-κB activity and increases sensitivity of prostate cancer cells to X-rays in vitro and in tumor xenografts in vivo. 61
28782644 2017
900
Identification of 7,8-Diacetoxy-3-Arylcoumarin Derivative as a Selective Cytotoxic and Apoptosis-inducing Agent in a Human Prostate Cancer Cell Line. 61
29061779 2017
901
Synthesis of substituted phenanthrene-9-benzimidazole conjugates: Cytotoxicity evaluation and apoptosis inducing studies. 61
28923381 2017
902
Antiproliferative Activity of Walnut (Juglans regia L.) Proteins and Walnut Protein Hydrolysates. 61
28945497 2017
903
Synthesis and biological evaluation of novel 6,11-dihydro-5H-benzo[e]pyrimido- [5,4-b][1,4]diazepine derivatives as potential c-Met inhibitors. 61
28938137 2017
904
Antiproliferative Dimeric Aporphinoid Alkaloids from the Roots of Thalictrum cultratum. 61
29131616 2017
905
Cytotoxic and acute toxicity studies of isoniazid derivatives. 61
29188778 2017
906
[68Ga]pentixafor for CXCR4 imaging in a PC-3 prostate cancer xenograft model - comparison with [18F]FDG PET/CT, MRI and ex vivo receptor expression. 61
29221153 2017
907
Divergent Anticancer Activity of Free and Formulated Camel Milk α-Lactalbumin. 61
28949782 2017
908
Notch1 suppresses prostate cancer cell invasion via the metastasis-associated 1-KiSS-1 metastasis-suppressor pathway. 61
29085444 2017
909
MiR-96 expression in prostate cancer and its effect on the target gene regulation. 61
29131261 2017
910
Design, synthesis and antitumor activity of Novel Sorafenib derivatives bearing pyrazole scaffold. 61
28927801 2017
911
Interplay between the gold nanoparticle sub-cellular localization, size, and the photon energy for radiosensitization. 61
29038517 2017
912
Dermaseptin-PH: A Novel Peptide with Antimicrobial and Anticancer Activities from the Skin Secretion of the South American Orange-Legged Leaf Frog, Pithecopus (Phyllomedusa) hypochondrialis. 61
29064402 2017
913
Synthesis and Structure-Activity Relationships of 4-Morpholino-7,8-Dihydro-5H-Thiopyrano[4,3-d]pyrimidine Derivatives Bearing Pyrazoline Scaffold. 61
29088090 2017
914
Mangiferin functionalized radioactive gold nanoparticles (MGF-198AuNPs) in prostate tumor therapy: green nanotechnology for production, in vivo tumor retention and evaluation of therapeutic efficacy. 61
28440368 2017
915
MD-Miner: a network-based approach for personalized drug repositioning. 61
28984195 2017
916
Constructing novel dihydrofuran and dihydroisoxazole analogues of isocombretastatin-4 as tubulin polymerization inhibitors through [3+2] reactions. 61
28803799 2017
917
Salen-Mn compounds induces cell apoptosis in human prostate cancer cells through promoting AMPK activity and cell autophagy. 61
29156794 2017
918
Direct Intranuclear Anticancer Drug Delivery via Polydimethylsiloxane Nanoparticles: in Vitro and in Vivo Xenograft Studies. 61
28902490 2017
919
Combination of Nexrutine and docetaxel suppresses NFκB-mediated activation of c-FLIP. 61
28485511 2017
920
Solubility-Improved 10-O-Substituted SN-38 Derivatives with Antitumor Activity. 61
28891271 2017
921
Rolling circle transcription-based polymeric siRNA nanoparticles for tumor-targeted delivery. 61
28373128 2017
922
A new biflavonoid and a new triterpene from the leaves of Garcinia paucinervis and their biological activities. 61
28550652 2017
923
Biotin-Pt (IV)-indomethacin hybrid: A targeting anticancer prodrug providing enhanced cancer cellular uptake and reversing cisplatin resistance. 61
28700961 2017
924
Conjugates of 18β-glycyrrhetinic acid derivatives with 3-(1H-benzo[d]imidazol-2-yl)propanoic acid as Pin1 inhibitors displaying anti-prostate cancer ability. 61
28838831 2017
925
Design, synthesis and biological evaluation of 1,3-diphenylbenzo[f][1,7]naphthyrdines. 61
28870801 2017
926
Synthesis and Antitumor Activity of Novel Arylpiperazine Derivatives Containing the Saccharin Moiety. 61
29109383 2017
927
A Study of the Anti-Cancer Effects of the Hexane Fraction of the Methanol Extract of Forsythiae Fructus. 61
29200739 2017
928
Artemisinin disrupts androgen responsiveness of human prostate cancer cells by stimulating the 26S proteasome-mediated degradation of the androgen receptor protein. 61
28708672 2017
929
Antioxidant and antiproliferative activity of blue corn and tortilla from native maize. 61
29086902 2017
930
In Silico and In Vitro Anticancer Activity of Isolated Novel Marker Compound from Chemically Modified Bioactive Fraction from Curcuma longa (NCCL). 61
29142426 2017
931
Downregulation of miR-199a-5p promotes prostate adeno-carcinoma progression through loss of its inhibition of HIF-1α. 61
29137361 2017
932
Proteomics approach to identify novel metastatic bone markers from the secretome of PC-3 prostate cancer cells. 61
28627741 2017
933
Isolation and purification of novel peptides derived from Sepia ink: Effects on apoptosis of prostate cancer cell PC‑3. 61
28731187 2017
934
Brachytherapy with Intratumoral Injections of Radiometal-Labeled Polymers That Thermoresponsively Self-Aggregate in Tumor Tissues. 61
28408533 2017
935
Development of a Recombinant Multifunctional Biomacromolecule for Targeted Gene Transfer to Prostate Cancer Cells. 61
28806522 2017
936
Tunicamycin induced endoplasmic reticulum stress promotes apoptosis of prostate cancer cells by activating mTORC1. 61
28978108 2017
937
CD44 regulates prostate cancer proliferation, invasion and migration via PDK1 and PFKFB4. 61